THE LUBRIZOL CORPORATION Form 10-Q
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
|
|
|
þ |
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended September 30, 2005
OR
|
|
|
o |
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission File Number 1-5263
THE LUBRIZOL CORPORATION
(Exact name of registrant as specified in its charter)
|
|
|
Ohio
(State or other jurisdiction of
incorporation or organization)
|
|
34-0367600
(I.R.S.Employer
Identification No.) |
29400 Lakeland Boulevard
Wickliffe, Ohio 44092-2298
(Address of principal executive offices)
(Zip Code)
(440) 943-4200
(Registrants telephone number, including area code)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by
Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for
such shorter period that the registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days.
Yes þ No o
Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of
the Exchange Act).
Yes þ No o
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the
Exchange Act).
Yes o No þ
Number of
the registrants common shares, without par value, outstanding
as of October 31, 2005: 68,006,224
THE LUBRIZOL CORPORATION
Quarterly Report on Form 10-Q
Quarter Ended September 30, 2005
Table of Contents
-2-
PART
I. FINANCIAL INFORMATION
Item 1. Financial Statements
THE LUBRIZOL CORPORATION
CONSOLIDATED STATEMENTS OF INCOME
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months |
|
|
Nine Months |
|
|
|
Ended September 30, |
|
|
Ended September 30, |
|
(in millions except per share data) |
|
2005 |
|
|
2004 |
|
|
2005 |
|
|
2004 |
|
|
Net sales |
|
$ |
1,013.4 |
|
|
$ |
915.9 |
|
|
$ |
3,035.8 |
|
|
$ |
2,207.8 |
|
Royalties and other revenues |
|
|
0.7 |
|
|
|
1.2 |
|
|
|
2.2 |
|
|
|
3.4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues |
|
|
1,014.1 |
|
|
|
917.1 |
|
|
|
3,038.0 |
|
|
|
2,211.2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of sales |
|
|
765.4 |
|
|
|
688.5 |
|
|
|
2,267.6 |
|
|
|
1,640.1 |
|
Selling and administrative expenses |
|
|
93.1 |
|
|
|
86.7 |
|
|
|
278.7 |
|
|
|
207.2 |
|
Research, testing and development expenses |
|
|
49.9 |
|
|
|
51.0 |
|
|
|
151.0 |
|
|
|
136.9 |
|
Amortization of intangible assets |
|
|
6.3 |
|
|
|
5.0 |
|
|
|
18.9 |
|
|
|
11.4 |
|
Write-off of (credit for) acquired in-process
research and development |
|
|
|
|
|
|
(1.5 |
) |
|
|
|
|
|
|
33.5 |
|
Restructuring and impairment charges |
|
|
7.4 |
|
|
|
10.5 |
|
|
|
18.9 |
|
|
|
17.9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total costs and expenses |
|
|
922.1 |
|
|
|
840.2 |
|
|
|
2,735.1 |
|
|
|
2,047.0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other income
(expense) net |
|
|
(0.8 |
) |
|
|
0.2 |
|
|
|
0.9 |
|
|
|
2.5 |
|
Interest income |
|
|
2.3 |
|
|
|
1.2 |
|
|
|
6.1 |
|
|
|
3.0 |
|
Interest expense |
|
|
(27.4 |
) |
|
|
(27.3 |
) |
|
|
(80.5 |
) |
|
|
(51.5 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
before income taxes |
|
|
66.1 |
|
|
|
51.0 |
|
|
|
229.4 |
|
|
|
118.2 |
|
Provision for income taxes |
|
|
21.3 |
|
|
|
19.6 |
|
|
|
77.1 |
|
|
|
45.1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations |
|
|
44.8 |
|
|
|
31.4 |
|
|
|
152.3 |
|
|
|
73.1 |
|
Discontinued operations net of tax |
|
|
3.8 |
|
|
|
0.8 |
|
|
|
4.9 |
|
|
|
0.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
48.6 |
|
|
$ |
32.2 |
|
|
$ |
157.2 |
|
|
$ |
73.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic earnings per share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Continuing operations |
|
$ |
0.66 |
|
|
$ |
0.60 |
|
|
$ |
2.24 |
|
|
$ |
1.41 |
|
Discontinued operations |
|
|
0.05 |
|
|
|
0.01 |
|
|
|
0.08 |
|
|
|
0.01 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income per share, basic |
|
$ |
0.71 |
|
|
$ |
0.61 |
|
|
$ |
2.32 |
|
|
$ |
1.42 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted
earnings per share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Continuing operations |
|
$ |
0.65 |
|
|
$ |
0.60 |
|
|
$ |
2.22 |
|
|
$ |
1.40 |
|
Discontinued operations |
|
|
0.05 |
|
|
|
0.01 |
|
|
|
0.07 |
|
|
|
0.01 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income per share, diluted |
|
$ |
0.70 |
|
|
$ |
0.61 |
|
|
$ |
2.29 |
|
|
$ |
1.41 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividends per share |
|
$ |
0.26 |
|
|
$ |
0.26 |
|
|
$ |
0.78 |
|
|
$ |
0.78 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average common shares
oustanding |
|
|
68.1 |
|
|
|
52.5 |
|
|
|
67.8 |
|
|
|
52.0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amounts shown are unaudited.
See accompanying notes to the financial statements.
-3-
THE LUBRIZOL CORPORATION
CONSOLIDATED BALANCE SHEETS
|
|
|
|
|
|
|
|
|
|
|
|
September 30, |
|
|
December 31, |
|
(in millions except share data) |
|
2005 |
|
|
2004 |
|
|
ASSETS |
|
|
|
|
|
|
|
|
Cash and short-term investments |
|
$ |
252.9 |
|
|
$ |
335.9 |
|
Receivables
net |
|
|
620.3 |
|
|
|
582.8 |
|
Inventories |
|
|
559.9 |
|
|
|
568.7 |
|
Other current assets |
|
|
112.8 |
|
|
|
110.6 |
|
|
|
|
|
|
|
|
Total current assets |
|
|
1,545.9 |
|
|
|
1,598.0 |
|
|
|
|
|
|
|
|
Property and
equipment at cost |
|
|
2,608.0 |
|
|
|
2,731.3 |
|
Less accumulated depreciation |
|
|
1,422.0 |
|
|
|
1,413.4 |
|
|
|
|
|
|
|
|
Property and
equipment net |
|
|
1,186.0 |
|
|
|
1,317.9 |
|
|
|
|
|
|
|
|
Goodwill |
|
|
1,144.5 |
|
|
|
1,153.8 |
|
Intangible
assets net |
|
|
412.0 |
|
|
|
437.1 |
|
Investments in non-consolidated companies |
|
|
8.0 |
|
|
|
7.4 |
|
Other assets |
|
|
51.7 |
|
|
|
52.1 |
|
|
|
|
|
|
|
|
TOTAL |
|
$ |
4,348.1 |
|
|
$ |
4,566.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES
AND SHAREHOLDERS EQUITY |
|
|
|
|
|
|
|
|
Short-term debt and current portion of long-term debt |
|
$ |
3.0 |
|
|
$ |
8.2 |
|
Accounts payable |
|
|
310.1 |
|
|
|
339.6 |
|
Accrued expenses and other current liabilities |
|
|
346.4 |
|
|
|
309.5 |
|
|
|
|
|
|
|
|
Total current liabilities |
|
|
659.5 |
|
|
|
657.3 |
|
|
|
|
|
|
|
|
Long-term debt |
|
|
1,689.6 |
|
|
|
1,964.1 |
|
Postretirement health-care obligations |
|
|
105.9 |
|
|
|
106.4 |
|
Noncurrent liabilities |
|
|
182.4 |
|
|
|
170.7 |
|
Deferred income taxes |
|
|
83.3 |
|
|
|
90.7 |
|
|
|
|
|
|
|
|
Total liabilities |
|
|
2,720.7 |
|
|
|
2,989.2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Minority interest in consolidated companies |
|
|
53.0 |
|
|
|
53.6 |
|
Contingencies and commitments
|
|
|
|
|
|
|
|
|
Shareholders equity: |
|
|
|
|
|
|
|
|
Preferred
stock without par value authorized
and unissued: |
|
|
|
|
|
|
|
|
Serial
preferred stock 2,000,000 shares |
|
|
|
|
|
|
|
|
Serial
preference shares 25,000,000 shares |
|
|
|
|
|
|
|
|
Common shares without par value: |
|
|
|
|
|
|
|
|
Authorized 120,000,000 shares |
|
|
|
|
|
|
|
|
Outstanding
67,994,273 shares as of September 30,
2005 after deducting 18,201,621 treasury shares,
66,778,865 shares as of December 31, 2004
after deducting 19,417,029 treasury shares |
|
|
660.3 |
|
|
|
610.6 |
|
Retained earnings |
|
|
1,001.6 |
|
|
|
897.4 |
|
Accumulated other comprehensive (loss) income |
|
|
(87.5 |
) |
|
|
15.5 |
|
|
|
|
|
|
|
|
Total shareholders equity |
|
|
1,574.4 |
|
|
|
1,523.5 |
|
|
|
|
|
|
|
|
TOTAL |
|
$ |
4,348.1 |
|
|
$ |
4,566.3 |
|
|
|
|
|
|
|
|
Amounts shown are unaudited.
See accompanying notes to the financial statements.
-4-
THE LUBRIZOL CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months |
|
|
|
Ended September 30, |
|
(in millions of dollars) |
|
2005 |
|
|
2004 |
|
|
Cash provided by (used for): |
|
|
|
|
|
|
|
|
Operating activities: |
|
|
|
|
|
|
|
|
Net income |
|
$ |
157.2 |
|
|
$ |
73.6 |
|
Adjustments to reconcile net income to cash provided
by operating activities: |
|
|
|
|
|
|
|
|
Depreciation and amortization |
|
|
135.6 |
|
|
|
108.8 |
|
Write-off of acquired in-process research and development |
|
|
|
|
|
|
33.5 |
|
Deferred income taxes |
|
|
(1.5 |
) |
|
|
(6.6 |
) |
Restructuring and impairment charges |
|
|
11.1 |
|
|
|
2.8 |
|
Change in current assets and liabilities, net of acquisitions and
divestitures: |
|
|
|
|
|
|
|
|
Receivables |
|
|
(73.3 |
) |
|
|
(79.5 |
) |
Inventories |
|
|
(12.1 |
) |
|
|
(17.8 |
) |
Accounts payable, accrued expenses and other current liabilities |
|
|
22.4 |
|
|
|
55.1 |
|
Other current assets |
|
|
11.5 |
|
|
|
9.4 |
|
Other items - net |
|
|
32.9 |
|
|
|
13.3 |
|
|
|
|
|
|
|
|
Total operating activities |
|
|
283.8 |
|
|
|
192.6 |
|
Investing activities: |
|
|
|
|
|
|
|
|
Capital expenditures |
|
|
(91.5 |
) |
|
|
(82.4 |
) |
Acquisitions
net of cash received and liabilities assumed |
|
|
|
|
|
|
(958.2 |
) |
Net proceeds from divestitures and sales of property and equipment |
|
|
17.2 |
|
|
|
1.8 |
|
Other items
net |
|
|
(0.2 |
) |
|
|
(0.3 |
) |
|
|
|
|
|
|
|
Total investing activities |
|
|
(74.5 |
) |
|
|
(1,039.1 |
) |
Financing activities: |
|
|
|
|
|
|
|
|
Changes in
short-term debt net |
|
|
(4.9 |
) |
|
|
(69.7 |
) |
Repayments of long-term debt |
|
|
(475.2 |
) |
|
|
(1,118.0 |
) |
Long-term borrowings |
|
|
213.8 |
|
|
|
1,743.2 |
|
Dividends paid |
|
|
(52.7 |
) |
|
|
(40.3 |
) |
Proceeds from the sale of common shares |
|
|
|
|
|
|
427.2 |
|
Payment of debt issuance costs |
|
|
|
|
|
|
(16.8 |
) |
Payment of treasury rate lock settlement |
|
|
|
|
|
|
(73.9 |
) |
Proceeds from the exercise of stock options |
|
|
37.4 |
|
|
|
12.8 |
|
|
|
|
|
|
|
|
Total financing activities |
|
|
(281.6 |
) |
|
|
864.5 |
|
Effect of exchange rate changes on cash |
|
|
(10.7 |
) |
|
|
7.4 |
|
|
|
|
|
|
|
|
Net (decrease) increase in cash and short-term
investments |
|
|
(83.0 |
) |
|
|
25.4 |
|
Cash and short-term investments at beginning of period |
|
|
335.9 |
|
|
|
258.7 |
|
|
|
|
|
|
|
|
Cash and short-term investments at end of period |
|
$ |
252.9 |
|
|
$ |
284.1 |
|
|
|
|
|
|
|
|
Amounts shown are unaudited.
See accompanying notes to the financial statements.
-5-
THE LUBRIZOL CORPORATION
Notes to Consolidated Financial Statements
September 30, 2005
1. Basis of Presentation
The accompanying unaudited consolidated financial statements have been prepared in accordance with
generally accepted accounting principles for interim financial information and Article 10 of
Regulation S-X. Accordingly, they do not include all of the information and footnotes required by
generally accepted accounting principles for complete financial statements. In the opinion of
management, all adjustments (consisting of normal recurring accruals unless otherwise noted)
considered necessary for a fair presentation have been included. Operating results for the three
and nine months ended September 30, 2005 are not necessarily indicative of the results that may be
expected for the year ending December 31, 2005.
The balance sheet at December 31, 2004 has been derived from the audited financial statements at
that date but does not include all of the information and footnotes required by accounting
principles generally accepted in the United States for complete financial statements.
2. Significant Accounting Policies
Net Income Per Share
Net income per share is computed by dividing net income by the weighted-average common shares
outstanding during the period, including contingently issuable shares. Net income per diluted
share includes the dilutive effect resulting from outstanding stock options and stock awards. Per
share amounts are computed as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months |
|
|
Nine Months |
|
|
|
Ended September 30, |
|
|
Ended September 30, |
|
(in millions except per share data) |
|
2005 |
|
|
2004 |
|
|
2005 |
|
|
2004 |
|
Numerator: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations |
|
$ |
44.8 |
|
|
$ |
31.4 |
|
|
$ |
152.3 |
|
|
$ |
73.1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Denominator: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average common shares
outstanding |
|
|
68.1 |
|
|
|
52.5 |
|
|
|
67.8 |
|
|
|
52.0 |
|
Dilutive effect of stock options and
awards |
|
|
0.9 |
|
|
|
0.5 |
|
|
|
0.8 |
|
|
|
0.4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Denominator for income from continuing
operations per share, diluted |
|
|
69.0 |
|
|
|
53.0 |
|
|
|
68.6 |
|
|
|
52.4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
per share, basic |
|
$ |
0.66 |
|
|
$ |
0.60 |
|
|
$ |
2.24 |
|
|
$ |
1.41 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
per share, diluted |
|
$ |
0.65 |
|
|
$ |
0.60 |
|
|
$ |
2.22 |
|
|
$ |
1.40 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average shares issuable upon the exercise of stock options that were excluded from the
diluted earnings per share calculations because they were antidilutive for the three and nine
months ended September 30, 2004 were 0.3 million and 1.3 million, respectively.
-6-
THE LUBRIZOL CORPORATION
Notes to Consolidated Financial Statements
September 30, 2005
Stock-Based Compensation
The company has elected the intrinsic value method to account for stock-based employee
compensation. The following table shows the pro forma effect on net income per share if the
company had applied the fair value recognition provisions of the Financial Accounting Standards
Boards (FASB) Statement of Financial Accounting Standard (SFAS) No. 123, Accounting for
Stock-Based Compensation, to stock-based employee compensation.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months |
|
|
Nine Months |
|
|
|
Ended September 30, |
|
|
Ended September 30, |
|
(in millions of dollars except per share data) |
|
2005 |
|
|
2004 |
|
|
2005 |
|
|
2004 |
|
Reported net income |
|
$ |
48.6 |
|
|
$ |
32.2 |
|
|
$ |
157.2 |
|
|
$ |
73.6 |
|
Plus: stock-based employee compensation
(net of tax) included in net income |
|
|
1.6 |
|
|
|
0.5 |
|
|
|
4.4 |
|
|
|
1.4 |
|
Less: stock-based employee compensation
(net of tax) using the fair value method |
|
|
(1.6 |
) |
|
|
(1.4 |
) |
|
|
(5.1 |
) |
|
|
(3.7 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Pro forma net income |
|
$ |
48.6 |
|
|
$ |
31.3 |
|
|
$ |
156.5 |
|
|
$ |
71.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reported net income per share, basic |
|
$ |
0.71 |
|
|
$ |
0.61 |
|
|
$ |
2.32 |
|
|
$ |
1.42 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pro forma net income per share, basic |
|
$ |
0.71 |
|
|
$ |
0.59 |
|
|
$ |
2.31 |
|
|
$ |
1.38 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reported net income per share, diluted |
|
$ |
0.70 |
|
|
$ |
0.61 |
|
|
$ |
2.29 |
|
|
$ |
1.41 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pro forma net income per share, diluted |
|
$ |
0.70 |
|
|
$ |
0.59 |
|
|
$ |
2.28 |
|
|
$ |
1.37 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
New Accounting Standards
In May 2005, the FASB issued SFAS No. 154, Accounting Changes and Error Corrections. This
standard establishes new standards on accounting for changes in accounting principles. Pursuant to
the new rules, all such changes must be accounted for by retrospective application to the financial
statements of prior periods unless it is impracticable to do so. SFAS No. 154 completely replaces
Accounting Principles Board (APB) Opinion No. 20 and SFAS No. 3, though it carries forward the
guidance in those pronouncements with respect to accounting for changes in estimates, changes in
the reporting entity and the correction of errors. This statement is effective for accounting
changes and error corrections completed by the company starting January 1, 2006. The company does
not believe the adoption of this standard will have a material impact on its financial position,
results of operations or cash flows.
In March 2005, the FASB issued Interpretation (FIN) No. 47, Accounting for Conditional
Asset-Retirement Obligations. This standard codifies SFAS No. 143, Asset-Retirement
Obligations, and states that companies must recognize a liability for the fair value of a legal
obligation to perform asset-retirement obligations that are conditional on a future event if the
amount can be reasonably estimated. Specifically, FIN No. 47 provides additional guidance on
whether the fair value is reasonably estimable. FIN No. 47 is effective for the company starting
December 31, 2005. The company does not believe the adoption of this standard will have a material
impact on its financial position, results of operations or cash flows.
In December 2004, the FASB issued SFAS No. 123(R), Share-Based Payment. This standard will
require compensation costs related to share-based payment transactions to be recognized in the
financial statements. With limited exceptions, the amount of compensation cost will be measured
based on the grant-date fair value of the equity or liability instruments issued. In addition,
liability awards will be remeasured each reporting period. Compensation cost will be recognized
over the period that an employee provides service in exchange for the award. This standard
-7-
THE LUBRIZOL CORPORATION
Notes to Consolidated Financial Statements
September 30, 2005
replaces SFAS No. 123 and supersedes APB Opinion No. 25, Accounting for Stock Issued to
Employees, and applies to all awards granted, modified, repurchased or cancelled after July 1,
2005. In April 2005, the Securities and Exchange Commission (SEC) amended the compliance date of
SFAS No. 123(R) through an amendment of Regulation S-X. The new effective date for the company is
January 1, 2006. The company currently is evaluating the provisions of this standard to determine
the impact on its consolidated financial statements. It is, however, expected to reduce
consolidated net income.
In December 2004, the FASB issued SFAS No. 153, Exchanges of Nonmonetary Assets. This standard
amended APB Opinion No. 29, Accounting for Nonmonetary Transactions, to eliminate the exception
from fair-value measurement for nonmonetary exchanges of similar productive assets. This standard
replaces this exception with a general exception from fair-value measurement for exchanges of
nonmonetary assets that do not have commercial substance. A nonmonetary exchange has commercial
substance if the future cash flows of the entity are expected to change significantly as a result
of the exchange. The provisions of SFAS No. 153 are
effective for nonmonetary asset exchanges occurring in fiscal periods
beginning after June 15, 2005. The companys adoption of this
standard did not have a material impact on the financial statements.
In November 2004, the FASB issued SFAS No. 151, Inventory Costs, to clarify the accounting for
abnormal amounts of idle facility expense, freight, handling costs and wasted material. This
standard requires that such items be recognized as current-period charges. The standard also
establishes the concept of normal capacity and requires the allocation of fixed production
overhead to inventory based on the normal capacity of the production facilities. Any unallocated
overhead must be recognized as an expense in the period incurred. This standard is effective for
inventory costs incurred starting January 1, 2006. The company does not believe the adoption of
this standard will have a material impact on its financial position, results of operations or cash
flows.
Use of Estimates
The preparation of consolidated financial statements in conformity with accounting principles
generally accepted in the United States of America requires management to make estimates and
assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent
assets and liabilities at the date of the financial statements and the reported amounts of revenues
and expenses during the reporting period. Actual results could differ from those estimates.
Reclassifications
Certain prior period amounts have been reclassified to conform to the current year presentation.
3. Acquisitions and Pro Forma Financial Information
On June 3, 2004, the company completed the acquisition of Noveon International, Inc. (Noveon
International) for cash of $920.2 million (inclusive of $32.9 million in certain seller expenses)
plus transaction costs of $11.4 million and less cash acquired of $103.0 million. In addition, the
company assumed $1,103.1 million of long-term indebtedness from Noveon International. With the
acquisition of Noveon International, the company has accelerated its program to attain a
substantial presence in the personal care and coatings markets by adding a number of higher-growth,
industry-leading products under highly recognizable brand names,
including Carbopol® ,
to the companys portfolio of lubricant and fuel additives and consumer products. Additionally,
Noveon International has a number of industry-leading specialty materials businesses, including
TempRite® chlorinated polyvinyl chloride and Estane® thermoplastic
polyurethane.
The acquisition and related costs were financed initially with the proceeds of a $2,450.0 million
364-day bridge credit facility. Shortly after the acquisition, the company repaid substantially
all of the assumed long-term debt of Noveon International with proceeds of the temporary bridge
loan. In addition, the temporary bridge loan was repaid in full in
-8-
THE LUBRIZOL CORPORATION
Notes to Consolidated Financial Statements
September 30, 2005
September 2004 with the
proceeds from the permanent financing obtained by the issuance of senior notes, debentures, bank
term loans and equity.
The consolidated balance sheets as of September 30, 2005 and December 31, 2004 reflect the
acquisition of Noveon International under the purchase method of accounting. The company recorded
the various assets acquired and liabilities assumed, primarily working capital accounts, of Noveon
International at their estimated fair values determined as of the acquisition date. Actuarial
valuations were completed for the projected pension and other post-employment benefit obligations
and were reflected in the purchase price allocation. Appraisals of long-lived assets and
identifiable intangible assets, including an evaluation of in-process research and development
(IPR&D) projects, were also obtained. Through June 2005, the company finalized certain aspects of
the purchase price allocation primarily surrounding the valuation of the property, plant and
equipment and the deferred tax accounts. In connection
with the acquisition of Noveon International, the company has targeted non-core businesses with
total revenues of approximately $500.0 million for disposition. This plan was contemplated at the
time of acquisition and plan activities have been underway since the fourth quarter of 2004. In
addition, through June 2005, the company continued the process of finalizing its reconciliation of
the underlying fixed-asset records to the respective appraisals. As a result of both of these
efforts, in the six months ended June 30, 2005, the company reduced the amount allocated to
property, plant and equipment by $55.2 million since December 31, 2004. Depreciation expense for
the three and six months ended June 30, 2005 included a related adjustment of $1.1 million and $2.3
million, respectively, representing the change in depreciation expense associated with the change
in the estimated fair values assigned to property, plant and equipment. In addition, the deferred
tax accounts were adjusted in June 2005 resulting in a decrease of $17.7 million to the net
deferred tax liabilities since December 31, 2004. The goodwill associated with the transaction
increased by $33.7 million in the six months ended June 30, 2005 representing the net impact of all
adjustments recorded. The allocation of the purchase price was complete as of June 30, 2005 and
the related actuarial valuations and appraisals obtained have been finalized.
The purchase price included the estimated fair value of IPR&D projects totaling $34.0 million that,
as of the acquisition date, had not yet reached technological feasibility and had no alternative
future use. As a result, the full amount allocated to IPR&D was expensed in 2004. The amount
charged to expense in the second quarter of 2004 was $35.0 million, of which $1.5 million was
reversed in the third quarter of 2004. This amount was subsequently adjusted to $34.0 million in
the fourth quarter of 2004. There were no changes to the valuation of IPR&D in 2005. The
inventory step-up to fair value totaled $24.2 million, of which $4.9 million was expensed in each
of the second and third quarters of 2004. As the remaining step-up relates to inventories
accounted for on the LIFO method of accounting, the company does not anticipate that additional
amounts of step-up will be expensed in the near term.
-9-
THE LUBRIZOL CORPORATION
Notes to Consolidated Financial Statements
September 30, 2005
The adjusted fair value of the assets acquired and liabilities assumed in connection with the
Noveon International acquisition was as follows as of June 30, 2005:
|
|
|
|
|
|
|
Fair Value of |
|
|
|
Net Assets |
|
(in millions of dollars) |
|
Acquired |
|
Receivables |
|
$ |
191.5 |
|
Inventories |
|
|
180.5 |
|
Other current assets |
|
|
47.4 |
|
Property and equipment |
|
|
559.6 |
|
Goodwill |
|
|
863.8 |
|
Intangible assets |
|
|
379.1 |
|
Other non-current assets |
|
|
18.2 |
|
|
|
|
|
Total assets |
|
|
2,240.1 |
|
|
|
|
|
|
|
|
|
|
Accounts payable |
|
|
129.4 |
|
Accrued expenses |
|
|
107.2 |
|
Current and long-term debt |
|
|
1,103.1 |
|
Noncurrent liabilities |
|
|
71.8 |
|
|
|
|
|
Total liabilities |
|
|
1,411.5 |
|
|
|
|
|
Increase in net assets from
acquisition |
|
$ |
828.6 |
|
|
|
|
|
The companys operating results for the nine months ended September 30, 2004 only include revenues
and expenses of Noveon International since June 3, 2004, the date of acquisition.
The following unaudited pro forma operating data is presented for the nine months ended September
30, 2004 as if the Noveon International acquisition had been completed at January 1, 2004. The pro
forma data gives effect to actual operating results prior to the acquisition. Adjustments to cost
of sales for the inventory step-up charge, fixed asset depreciation, intangible asset amortization,
the write-off of (credit for) acquired IPR&D, interest expense and income taxes related to the
acquisition are reflected in the pro forma data. In addition, the company assumed that the bridge
loan obtained at the time of the transaction closing was not replaced with the permanent long-term
financing consisting of both debt and equity until the end of April, the fourth month in the period
presented. These pro forma amounts do not purport to be indicative of the results that actually
would have been obtained if the acquisition had occurred as of the beginning of the period
presented or that may be obtained in the future.
-10-
THE LUBRIZOL CORPORATION
Notes to Consolidated Financial Statements
September 30, 2005
|
|
|
|
|
|
|
Nine Months |
|
|
|
Ended |
|
(in millions of dollars except per share data) |
|
September 30, 2004 |
|
Total revenues |
|
$ |
2,748.8 |
|
|
|
|
|
Income from continuing operations |
|
$ |
96.2 |
|
Discontinued operations |
|
|
0.4 |
|
|
|
|
|
Net income |
|
$ |
96.6 |
|
|
|
|
|
|
|
|
|
|
Basic earnings per share: |
|
|
|
|
Continuing operations |
|
$ |
1.60 |
|
Discontinued operations |
|
|
0.01 |
|
|
|
|
|
Net income per share, basic |
|
$ |
1.61 |
|
|
|
|
|
|
|
|
|
|
Diluted earnings per share: |
|
|
|
|
Continuing operations |
|
$ |
1.59 |
|
Discontinued operations |
|
|
0.01 |
|
|
|
|
|
Net income per share, diluted |
|
$ |
1.60 |
|
|
|
|
|
On January 30, 2004, the company completed the acquisition of the coatings hyperdispersants
business of Avecia. This business is headquartered in Blackley, United Kingdom and develops,
manufactures and markets high-value additives that are based on polymeric dispersion technology and
used in coatings and inks. These products enrich and strengthen color while reducing production
costs and solvent emissions, and are marketed under the brand names Solsperse®,
Solplus® and Solthix®. Historical annual revenues of this business are
approximately $50.0 million. The 2004 historical results only include revenues and expenses of
hyperdispersants since the date of acquisition.
4. Divestitures
In September 2005, the company sold certain assets and liabilities of its U.S. and U.K. Lubrizol
Performance Systems (LPS) operations, which were included in the Lubricant Additives segment. The
company retained the tax-related assets and liabilities of its LPS operations. The company
received cash of $13.5 million for these net assets. The LPS operations meet the definition of a
component of an entity and have been accounted for as a discontinued operation under SFAS No.
144, Accounting for the Impairment or Disposal of Long-Lived Assets. The results of the LPS
operations have been classified as discontinued operations in all periods presented.
Revenue from discontinued operations was $6.6 million and $20.3 million for the three and nine
months ended September 30, 2005, respectively, compared to $5.4 million and $11.5 million for the
corresponding periods in the prior year. Income from discontinued operations was $0.9 million and
$2.0 million for the three and nine months ended September 30, 2005, respectively, compared to $0.8
million and $0.5 million for the corresponding periods in the prior year. The three and nine
months ended September 30, 2005 included a $4.2 million pre-tax gain ($2.9 million net of tax).
Income from discontinued operations are net of tax expenses of $0.5 million and $0.7 million for
the three and nine months ended September 30, 2005, respectively, compared to tax expense of $0.1
million for the three months ended September 30, 2004 and tax credits of $0.2 million for the nine
months ended September 30, 2004.
-11-
THE LUBRIZOL CORPORATION
Notes to Consolidated Financial Statements
September 30, 2005
The companys consolidated balance sheet as of December 31, 2004 included $16.1 million in current
assets, $3.1 million in property, plant and equipment, $1.1 million in other assets, $10.9 million
in liabilities and $0.9 million in other comprehensive income currency translation adjustment
pertaining to LPS.
5. Inventory
The companys inventory was comprised of the following as of September 30, 2005 and December 31,
2004:
|
|
|
|
|
|
|
|
|
|
|
September 30, |
|
|
December 31, |
|
(in millions of dollars) |
|
2005 |
|
|
2004 |
|
Finished products |
|
$ |
320.4 |
|
|
$ |
311.2 |
|
Products in process |
|
|
79.6 |
|
|
|
75.9 |
|
Raw materials |
|
|
132.0 |
|
|
|
153.1 |
|
Supplies and engine test parts |
|
|
27.9 |
|
|
|
28.5 |
|
|
|
|
|
|
|
|
Total inventory |
|
$ |
559.9 |
|
|
$ |
568.7 |
|
|
|
|
|
|
|
|
6. Goodwill and Intangible Assets
The major components of the companys identifiable intangible assets are customer lists,
technology, trademarks, patents, land-use rights and non-compete agreements. Excluding the
non-amortized trademarks, which are indefinite-lived and will not be amortized, the intangible
assets are amortized over the lives of the respective agreements or other periods of value, which
range between three and forty years. We assess the indefinite-lived trademarks for impairment
separately from goodwill.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
September 30, 2005 |
|
|
December 31, 2004 |
|
|
|
Gross |
|
|
|
|
|
|
Gross |
|
|
|
|
|
|
Carrying |
|
|
Accumulated |
|
|
Carrying |
|
|
Accumulated |
|
(in millions of dollars) |
|
Amount |
|
|
Amortization |
|
|
Amount |
|
|
Amortization |
|
Amortized intangible assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Customer lists |
|
$ |
152.5 |
|
|
$ |
13.5 |
|
|
$ |
157.3 |
|
|
$ |
6.8 |
|
Technology |
|
|
144.4 |
|
|
|
33.1 |
|
|
|
144.4 |
|
|
|
25.4 |
|
Trademarks |
|
|
24.5 |
|
|
|
3.8 |
|
|
|
24.4 |
|
|
|
2.3 |
|
Patents |
|
|
12.1 |
|
|
|
2.2 |
|
|
|
13.2 |
|
|
|
1.5 |
|
Land-use rights |
|
|
7.2 |
|
|
|
0.9 |
|
|
|
7.1 |
|
|
|
0.8 |
|
Non-compete agreements |
|
|
8.9 |
|
|
|
5.3 |
|
|
|
8.9 |
|
|
|
3.8 |
|
Other |
|
|
5.5 |
|
|
|
0.7 |
|
|
|
5.9 |
|
|
|
0.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total amortized
intangible assets |
|
|
355.1 |
|
|
|
59.5 |
|
|
|
361.2 |
|
|
|
41.1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-amortized trademarks |
|
|
116.4 |
|
|
|
|
|
|
|
117.0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
471.5 |
|
|
$ |
59.5 |
|
|
$ |
478.2 |
|
|
$ |
41.1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Annual intangible amortization expense for the next five years will approximate $25.6 million for
2005, $25.4 million in 2006, $23.9 million in 2007, $22.4 million in 2008 and $20.6 million in
2009.
-12-
THE LUBRIZOL CORPORATION
Notes to Consolidated Financial Statements
September 30, 2005
The carrying amount of goodwill by reporting segment as of September 30, 2005 is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lubricant |
|
|
Specialty |
|
|
|
|
(in millions of dollars) |
|
Additives |
|
|
Chemicals |
|
|
Total |
|
Balance, January 1, 2005 |
|
$ |
100.9 |
|
|
$ |
1,052.9 |
|
|
$ |
1,153.8 |
|
Goodwill
adjustments |
|
|
|
|
|
|
32.6 |
|
|
|
32.6 |
|
Translation & other
adjustments |
|
|
(2.2 |
) |
|
|
(39.7 |
) |
|
|
(41.9 |
) |
|
|
|
|
|
|
|
|
|
|
Balance, September 30, 2005 |
|
$ |
98.7 |
|
|
$ |
1,045.8 |
|
|
$ |
1,144.5 |
|
|
|
|
|
|
|
|
|
|
|
The adjustment to goodwill recorded in 2005 relates to the Noveon International purchase
accounting.
Goodwill is tested for impairment at the reporting unit level annually as of October 1 of each year
or if events or circumstances occur that would more likely than not reduce the fair value of a
reporting unit below its carrying amount.
7. Comprehensive Income
Total comprehensive income for the three and nine months ended September 30, 2005 and 2004 was
comprised of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months |
|
|
Nine Months |
|
|
|
Ended September 30, |
|
|
Ended September 30, |
|
(in millions of dollars) |
|
2005 |
|
|
2004 |
|
|
2005 |
|
|
2004 |
|
Net income |
|
$ |
48.6 |
|
|
$ |
32.2 |
|
|
$ |
157.2 |
|
|
$ |
73.6 |
|
Foreign currency translation adjustment |
|
|
1.0 |
|
|
|
8.4 |
|
|
|
(106.1 |
) |
|
|
0.7 |
|
Pension plan minimum liability |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.3 |
|
Unrealized gains - natural gas
hedges |
|
|
0.8 |
|
|
|
|
|
|
|
1.0 |
|
|
|
0.2 |
|
Unrealized gains - interest rate
swaps |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2.1 |
|
Amortization of treasury rate locks |
|
|
0.7 |
|
|
|
(40.0 |
) |
|
|
2.1 |
|
|
|
(48.0 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total comprehensive income |
|
$ |
51.1 |
|
|
$ |
0.6 |
|
|
$ |
54.2 |
|
|
$ |
28.9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8. Segment Reporting
The company is organized into two operating and reporting segments: Lubricant Additives and
Specialty Chemicals. The Lubricant Additives segment, also referred to as Lubrizol Additives,
represented 57% and 56% of the companys consolidated revenues for the three and nine months ended
September 30, 2005, respectively, and is comprised of the companys businesses in engine additives,
specialty driveline and industrial oil additives and services and equipment. The Specialty
Chemicals segment, also referred to as the Noveon segment, represented 43% and 44% of the companys
consolidated revenues for the three and nine months ended September 30, 2005, respectively, and is
comprised of the businesses of the acquired Noveon International and the former performance
chemicals group of the company.
-13-
THE LUBRIZOL CORPORATION
Notes to Consolidated Financial Statements
September 30, 2005
Lubricant Additives consists of three product lines: engine additives; specialty driveline and
industrial oil additives; and services and equipment. Engine additives is comprised of additives
for lubricating engine oils, such as for gasoline, diesel, marine and stationary gas engines and
additive components, and additives for fuel products and refinery and oil field chemicals. In
addition, this product line sells additive components and viscosity improvers within its lubricant
and fuel additives product areas. Specialty driveline and industrial oil additives is comprised of
additives for driveline oils, such as automatic transmission fluids, gear oils and tractor
lubricants and industrial oil additives, such as additives for hydraulic, grease and metalworking
fluids, as well as compressor lubricants. Services and equipment is comprised of particulate
emission trap devices, FluiPak® sensor systems and outsourcing strategies for supply
chain and knowledge center management. Lubricant Additives product lines are produced generally in
company-owned shared manufacturing facilities and sold largely to a common customer base.
The Specialty Chemicals segment consists of consumer specialties, specialty materials and
performance coatings product lines. The consumer specialties product line is characterized by
global production of acrylic thickeners, specialty monomers, film formers, fixatives, emollients,
silicones, surfactants, botanicals, active pharmaceutical
ingredients and intermediates, process chemicals, benzoate preservatives, fragrances, defoamers,
synthetic food and technical dyes, rubber and lubricant antioxidants and rubber accelerators. The
company markets products in the consumer specialties product line to the following primary end-use
industries: personal care, food and beverage, automotive, aerospace and pharmaceuticals. The
consumer specialties products are sold to customers worldwide and these customers include major
manufacturers of cosmetics, personal care products, water soluble polymers, household products,
soft drinks and food products and major manufacturers in the automotive and aerospace industries.
The specialty materials product line is characterized by products such as chlorinated polyvinyl
chloride (CPVC) resins and compounds and is also a producer of thermoplastic polyurethane (TPU) and
cross-linked polyethylene compounds (PEX). The company markets products of specialty materials
through the primary product category of specialty plastics. Specialty materials products are sold
to a diverse customer base comprised of major manufacturers in the construction, automotive,
telecommunications, electronics and recreation industries. The performance coatings product line
includes high-performance polymers for specialty paper, printing and packaging, industrial and
architectural specialty coatings and textile applications. The company markets the performance
coatings products through the primary product categories of performance polymers and coatings and
textile performance chemicals. Performance coatings products serve major companies in the
specialty paper, printing and packaging, paint and coatings, and textile industries.
The company primarily evaluates performance and allocates resources based on segment operating
income, defined as revenues less expenses identifiable to the product lines included within each
segment, as well as projected future returns. Segment operating income will reconcile to
consolidated income from continuing operations before income taxes by deducting corporate expenses
and corporate other income (expense) that are not attributed to the operating segments, the
write-off of (credit for) acquired IPR&D, restructuring and impairment charges and net interest
expense.
-14-
THE LUBRIZOL CORPORATION
Notes to Consolidated Financial Statements
September 30, 2005
The following table presents a summary of the results of the companys reportable segments for the
three and nine months ended September 30, 2005 and 2004:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months |
|
|
Nine Months |
|
|
|
Ended September 30, |
|
|
Ended September 30, |
|
(in millions of dollars) |
|
2005 |
|
|
2004 |
|
|
2005 |
|
|
2004 |
|
Revenues from external customers: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lubricant Additives |
|
$ |
574.1 |
|
|
$ |
509.3 |
|
|
$ |
1,704.9 |
|
|
$ |
1,517.8 |
|
Specialty Chemicals |
|
|
440.0 |
|
|
|
407.8 |
|
|
|
1,333.1 |
|
|
|
693.4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues |
|
$ |
1,014.1 |
|
|
$ |
917.1 |
|
|
$ |
3,038.0 |
|
|
$ |
2,211.2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Segment operating income: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lubricant Additives |
|
$ |
68.6 |
|
|
$ |
66.0 |
|
|
$ |
220.7 |
|
|
$ |
201.6 |
|
Specialty Chemicals |
|
|
47.5 |
|
|
|
29.6 |
|
|
|
150.5 |
|
|
|
46.0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Segment operating income |
|
|
116.1 |
|
|
|
95.6 |
|
|
|
371.2 |
|
|
|
247.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate expenses |
|
|
(16.7 |
) |
|
|
(10.5 |
) |
|
|
(47.4 |
) |
|
|
(32.2 |
) |
Corporate other income (expense) |
|
|
(0.8 |
) |
|
|
1.0 |
|
|
|
(1.1 |
) |
|
|
2.7 |
|
Credit for (write-off of) acquired
IPR&D |
|
|
|
|
|
|
1.5 |
|
|
|
|
|
|
|
(33.5 |
) |
Restructuring and impairment
charges |
|
|
(7.4 |
) |
|
|
(10.5 |
) |
|
|
(18.9 |
) |
|
|
(17.9 |
) |
Interest expense net |
|
|
(25.1 |
) |
|
|
(26.1 |
) |
|
|
(74.4 |
) |
|
|
(48.5 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
before income taxes |
|
$ |
66.1 |
|
|
$ |
51.0 |
|
|
$ |
229.4 |
|
|
$ |
118.2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The companys total assets by segment were as follows:
|
|
|
|
|
|
|
|
|
|
|
September 30, |
|
|
December 31, |
|
(in millions of dollars) |
|
2005 |
|
|
2004 |
|
Segment total assets: |
|
|
|
|
|
|
|
|
Lubricant Additives |
|
$ |
1,322.0 |
|
|
$ |
1,337.1 |
|
Specialty Chemicals |
|
|
2,542.7 |
|
|
|
2,669.2 |
|
|
|
|
|
|
|
|
Total segment assets |
|
|
3,864.7 |
|
|
|
4,006.3 |
|
|
|
|
|
|
|
|
|
|
Corporate assets |
|
|
483.4 |
|
|
|
560.0 |
|
|
|
|
|
|
|
|
Total consolidated assets |
|
$ |
4,348.1 |
|
|
$ |
4,566.3 |
|
|
|
|
|
|
|
|
-15-
THE LUBRIZOL CORPORATION
Notes to Consolidated Financial Statements
September 30, 2005
9. Pension and Postretirement Benefits
The components of net periodic pension cost and postretirement benefits costs consist of the
following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months |
|
|
Nine Months |
|
|
|
Ended September 30, |
|
|
Ended September 30, |
|
(in millions of dollars) |
|
2005 |
|
|
2004 |
|
|
2005 |
|
|
2004 |
|
Pension benefits: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Service cost
benefits earned
during period |
|
$ |
7.0 |
|
|
$ |
7.0 |
|
|
$ |
21.2 |
|
|
$ |
15.7 |
|
Interest cost on projected
benefit obligation |
|
|
7.8 |
|
|
|
7.3 |
|
|
|
23.8 |
|
|
|
20.1 |
|
Expected return on plan assets |
|
|
(6.7 |
) |
|
|
(6.9 |
) |
|
|
(20.3 |
) |
|
|
(20.1 |
) |
Amortization of prior service costs |
|
|
0.6 |
|
|
|
0.5 |
|
|
|
1.7 |
|
|
|
1.5 |
|
Amortization of initial net asset
obligation |
|
|
|
|
|
|
(0.1 |
) |
|
|
0.1 |
|
|
|
(0.5 |
) |
Settlements loss |
|
|
|
|
|
|
5.7 |
|
|
|
|
|
|
|
5.7 |
|
Recognized net actuarial loss |
|
|
1.3 |
|
|
|
0.9 |
|
|
|
3.9 |
|
|
|
2.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net periodic benefit cost |
|
$ |
10.0 |
|
|
$ |
14.4 |
|
|
$ |
30.4 |
|
|
$ |
25.0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other benefits: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Service cost
benefits earned
during period |
|
$ |
0.3 |
|
|
$ |
0.6 |
|
|
$ |
1.4 |
|
|
$ |
1.9 |
|
Interest cost on projected
benefit obligation |
|
|
1.3 |
|
|
|
1.6 |
|
|
|
4.5 |
|
|
|
5.1 |
|
Amortization of prior service costs |
|
|
(2.1 |
) |
|
|
(1.5 |
) |
|
|
(5.5 |
) |
|
|
(4.6 |
) |
Recognized net actuarial loss |
|
|
0.5 |
|
|
|
0.7 |
|
|
|
1.6 |
|
|
|
1.9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net periodic benefit cost |
|
$ |
|
|
|
$ |
1.4 |
|
|
$ |
2.0 |
|
|
$ |
4.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected employer contributions worldwide for pension benefits in 2005 approximate $38.1
million for the qualified plans, of which $35.7 million was paid in the nine months ended September
30, 2005. The portion of the 2005 total expected contributions attributable to the U.S. qualified
pension plans is $23.6 million, all of which was paid in the nine months ended September 30, 2005.
The non-qualified pension plans and postretirement benefit plans are unfunded. As a result, the
2005 expected contributions to these plans of $2.1 million and $4.7 million, respectively,
represent actuarial estimates of future assumed payments based on historic retirement and payment
patterns as well as medical trend rates and historical claim information, as appropriate.
As part of the Noveon International integration efforts to provide consistent benefits, the company
communicated to employees in May 2005 changes to the benefits structure of certain of its U.S.
pension and postretirement benefit plans. This communication triggered a remeasurement of the
related benefit obligations and net periodic benefit cost in 2005 for both the legacy Noveon
International U.S. pension plans as well as for the U.S. postretirement benefit plan. As a result
of the second quarter remeasurement, the discount rate for the legacy Noveon International U.S.
pension plans was reduced by 25 basis points to 5.75%. In addition, the discount rate for the U.S.
postretirement benefit plan was reduced by 50 basis points to 5.75%. The net impact of the benefit
and actuarial assumption changes reduced our aggregate net periodic pension and postretirement
benefit cost by $1.3 million and $2.2 million in the
-16-
THE LUBRIZOL CORPORATION
Notes to Consolidated Financial Statements
September 30, 2005
three and nine months ended September 30,
2005, respectively. The annual savings resulting from this benefits change projected for 2005 are
estimated at approximately $3.5 million and the annualized savings are estimated to be
approximately $5.3 million.
10. Restructuring and Impairment Charges
In the three and nine months ended September 30, 2005, the company recorded aggregate restructuring
charges of $1.2 million and $12.7 million, respectively. The restructuring charges were related
primarily to the phase-out of manufacturing facilities in both the Lubricant Additives and
Specialty Chemicals segments as well as other workforce reductions. The company also recorded an
impairment charge of $6.2 million in September 2005 at one
of our European Specialty Chemicals segment facilities based on the
fair value estimates obtained in our divestiture proceedings.
The following table shows the reconciliation of the restructuring liability since December 31, 2004
by major restructuring activity:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liability |
|
|
|
|
|
|
|
|
|
|
Restructuring |
|
|
Liability |
|
|
|
December 31, |
|
|
Restructuring |
|
|
|
|
|
|
Asset |
|
|
September 30, |
|
(in millions of dollars) |
|
2004 |
|
|
Charges |
|
|
Cash Paid |
|
|
Impairments |
|
|
2005 |
|
Coatings plant closures
and workforce reductions |
|
$ |
|
|
|
$ |
7.6 |
|
|
$ |
(1.7 |
) |
|
$ |
(4.2 |
) |
|
$ |
1.7 |
|
Bromborough, United Kingdom closure |
|
|
|
|
|
|
4.2 |
|
|
|
(1.8 |
) |
|
|
(0.7 |
) |
|
|
1.7 |
|
Corporate workforce reductions |
|
|
2.7 |
|
|
|
0.7 |
|
|
|
(3.0 |
) |
|
|
|
|
|
|
0.4 |
|
Noveon International restructuring
liabilities assumed |
|
|
6.1 |
|
|
|
0.2 |
|
|
|
(4.6 |
) |
|
|
|
|
|
|
1.7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
8.8 |
|
|
$ |
12.7 |
|
|
$ |
(11.1 |
) |
|
$ |
(4.9 |
) |
|
$ |
5.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
In May 2005, the company announced the reorganization of the Specialty Chemicals performance
coatings product line. This product line includes businesses acquired from Noveon International as
well as businesses included in the companys legacy operations. In connection with the
reorganization, management eliminated 19 positions in North America and Europe. These reductions
were completed by September 30, 2005 and resulted in a severance-related charge of $0.1 million and
$1.3 million recorded in the three and nine months ended September 30, 2005, respectively.
In the first quarter of 2005, management made the decision and the announcement to close two
Specialty Chemicals performance coatings production facilities in the United States. The aggregate
restructuring charge recorded for these closures for the three months ended September 30, 2005 was
$0.5 million, comprised primarily of severance costs. The aggregate restructuring charge recorded
for these closures for the nine months ended September 30, 2005 was $6.3 million, comprised of $4.2
million in asset impairments, $0.9 million in exit costs and $1.2 million in severance costs. The
company estimates it will incur cumulative severance costs of approximately $2.1 million relating
to these closures. An impairment charge for both plants was recorded in the first quarter of 2005
to reflect the related assets at their estimated fair values. The estimated fair value of the
assets was determined primarily from third-party appraisals. Production for these sites will be
transferred to other facilities in the United States. The facility in Mountaintop, Pennsylvania
was closed in October of 2005, while the facility in Linden, New Jersey is scheduled to close in
the second quarter of 2006. These closures will result in a workforce reduction of 62 employees by
the second quarter of 2006.
In December 2004, management made the decision to close the Lubricant Additives manufacturing
facility in Bromborough, United Kingdom. The company announced this decision in January 2005. The
company determined, as of December 31, 2004, that an impairment of certain of the facilitys
long-lived assets had been triggered by this decision in the fourth quarter of 2004. As a result,
a $17.0 million impairment charge was recorded in December 2004
-17-
THE LUBRIZOL CORPORATION
Notes to Consolidated Financial Statements
September 30, 2005
to reflect the related assets at
their estimated fair values. The estimated fair value of the assets was determined using a
discounted cash flow model. Production phase-out of this site began in the third quarter of 2005
and is expected to be completed by late 2006. During this phase-out, United Kingdom production
will be transferred to facilities in France and the United States. Approximately 69 employees will
be impacted by this closure. The aggregate restructuring charge recorded for this closure for the
three months ended September 30, 2005 was $0.8 million, comprised primarily of severance costs.
The aggregate restructuring charge recorded for this closure for the nine months ended September
30, 2005 was $4.2 million, comprised of $0.7 million in asset impairments, $0.5 million in exit
costs and $3.0 million in severance costs. The company currently anticipates that pre-tax charges
for cash expenditures of approximately $13.5 million to $15.5 million will be incurred in 2005
through 2007 to satisfy
severance and retention obligations, plant dismantling, site restoration and other site
environmental evaluation costs and lease-related costs, including the $4.2 million recorded through
September 30, 2005.
In 2004, the company eliminated more than 100 positions, primarily affecting technical and
commercial employees located at the Wickliffe, Ohio headquarters. Most of these workforce
reductions were related to the restructuring following the acquisition of Noveon International.
These reductions were completed by December 31, 2004. In the second quarter of 2005, the company
began a process of identifying further opportunities to increase efficiency and productivity,
reduce costs and support the companys integration strategy of the Noveon International
acquisition. As a result, the company reduced headcount in the general and administrative area of
its headquarters offices in Ohio. Through these restructuring efforts, the company eliminated
seven positions resulting in a severance-related charge of $0.7 million in the nine months ended
September 30, 2005. All of the affected employees had left their positions by June 30, 2005 and
the remaining personnel-related costs are expected to be paid by 2006. The company continues to
evaluate other opportunities to integrate general and administrative functions. As such
opportunities are identified in future periods, the company expects further restructuring charges.
The company assumed a restructuring liability of $7.2 million in 2004 relating to the legacy
operations of Noveon International. This liability was $6.1 million at December 31, 2004 and $1.7
million at September 30, 2005.
The charges for these cost reduction initiatives and impairments are reported as a separate line
item in the consolidated income statements, entitled Restructuring and impairment charges and are
included in the Total cost and expenses subtotal on the consolidated income statements.
11. Debt
On September 14, 2005, certain wholly owned foreign subsidiaries of the company entered into a new
five-year unsecured 250.0 million revolving credit agreement. This credit agreement permits
these designated foreign subsidiaries to borrow at variable rates based on EURIBOR plus a specified
credit spread. The company has guaranteed all obligations of the borrowers under the credit
agreement. On September 20, 2005, Europe Chemical Holdings C.V. borrowed 175.0 million under
this agreement. During the three and nine months ended September 30, 2005, the company repaid
$350.0 million and $475.0 million, respectively against the bank term loan. The balance
outstanding at September 30, 2005 under the term-loan arrangement was $25.0 million.
-18-
THE LUBRIZOL CORPORATION
Notes to Consolidated Financial Statements
September 30, 2005
12. Shareholders Equity
The following table summarizes the changes in shareholders equity since January 1, 2005:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shareholders Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated |
|
|
|
|
|
|
Number of |
|
|
|
|
|
|
|
|
|
|
Other |
|
|
|
|
|
|
Shares |
|
|
Common |
|
|
Retained |
|
|
Comprehensive |
|
|
|
|
|
|
Outstanding |
|
|
Shares |
|
|
Earnings |
|
|
Income (Loss) |
|
|
Total |
|
(in millions) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, January 1, 2005 |
|
|
66.8 |
|
|
$ |
610.6 |
|
|
$ |
897.4 |
|
|
$ |
15.5 |
|
|
$ |
1,523.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive income: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
|
|
|
|
|
|
|
|
|
157.2 |
|
|
|
|
|
|
|
157.2 |
|
Other comprehensive loss |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(103.0 |
) |
|
|
(103.0 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
54.2 |
|
Dividends declared |
|
|
|
|
|
|
|
|
|
|
(53.0 |
) |
|
|
|
|
|
|
(53.0 |
) |
Deferred stock compensation |
|
|
0.2 |
|
|
|
8.0 |
|
|
|
|
|
|
|
|
|
|
|
8.0 |
|
Common shares treasury: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares issued upon exercise
of stock options and awards |
|
|
1.0 |
|
|
|
41.7 |
|
|
|
|
|
|
|
|
|
|
|
41.7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, September 30, 2005 |
|
|
68.0 |
|
|
$ |
660.3 |
|
|
$ |
1,001.6 |
|
|
$ |
(87.5 |
) |
|
$ |
1,574.4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
13. Contingencies
The company has numerous purchase commitments for materials, supplies and energy in the ordinary
course of business. The company has numerous sales commitments for product supply contracts in the
ordinary course of business.
General
The patent infringement suit filed against the company by Afton Chemical Company in federal court
in Virginia in the second quarter of 2005 was dismissed with finality on October 27, 2005. The
company incurred no liability.
In addition, there are pending or threatened claims, lawsuits and administrative proceedings
against the company or its subsidiaries, all arising from the ordinary course of business with
respect to commercial, product liability and environmental matters, which seek remedies or damages.
The company believes that any liability that finally may be determined with respect to commercial
and product liability claims should not have a material adverse effect on the companys
consolidated financial position, results of operations or cash flows. From time to time, the
company is also involved in legal proceedings as a plaintiff involving contract, patent protection,
environmental and other matters. Gain contingencies, if any, are recognized when they are
realized.
Environmental
The companys environmental engineers and consultants review and monitor environmental issues at
operating facilities and, where appropriate, the company initiates corrective and/or preventive
environmental projects to ensure
-19-
THE LUBRIZOL CORPORATION
Notes to Consolidated Financial Statements
September 30, 2005
environmental compliance and safe and lawful activities at its
current operations. The company also conducts compliance and management systems audits.
The company and its subsidiaries are generators of both hazardous and non-hazardous wastes, the
treatment, storage, transportation and disposal of which are regulated by various laws and
governmental regulations. These laws and
regulations generally impose liability for costs to investigate and remediate contamination without
regard to fault and, under certain circumstances, liability may be joint and several resulting in
one party being held responsible for the entire obligation. Liability may also include damages to
natural resources. Although the company believes past operations were in substantial compliance
with the then-applicable regulations, either the company or the predecessor of Noveon
International, the Performance Materials Segment of Goodrich Corporation (Goodrich), has been
designated under a countrys laws and/or regulations as a potentially responsible party (PRP) in
connection with several sites including both third party sites and/or current operating facilities.
The company participates in the remediation process for onsite and third-party waste management
sites at which the company has been identified as a PRP. This process includes investigation,
remedial action selection and implementation, as well as discussions and negotiations with other
parties, which primarily include PRPs, past owners and operators and governmental agencies. The
estimates of environmental liabilities are based on the results of this process. Inherent
uncertainties exist in these estimates primarily due to unknown conditions, changing governmental
regulations and legal standards regarding liability, remediation standards and evolving
technologies for managing investigations and remediations. The company revises its estimates
accordingly as events in this process occur and additional information is obtained.
The companys environmental reserves, measured on an undiscounted basis, totaled $27.3 million at
September 30, 2005 and $26.4 million at December 31, 2004. Of these amounts, $3.5 million and $4.5
million were included in accrued expenses and other current liabilities at September 30, 2005 and
December 31, 2004, respectively. The companys September 30, 2005 balance sheet includes
liabilities, measured on an undiscounted basis, of $17.8 million to cover future environmental
expenditures for Noveon International sites either payable by Noveon International or indemnifiable
by Goodrich. Accordingly, the current portion of the Noveon International environmental
obligations of $0.7 million is recorded in accrued expenses and other current liabilities and $0.4
million of the recovery due from Goodrich is recorded in receivables. Non-current Noveon
International liabilities include $17.1 million and other assets include $2.6 million reflecting
the recovery due from Goodrich. Goodrich provided Noveon International with an indemnity for
various environmental liabilities. The company estimates Goodrichs share of such currently
identified liabilities under the indemnity, which extends through February 2011, to be
approximately $3.0 million. There are specific environmental contingencies for company-owned sites
for which third parties such as past owners and/or operators are the named PRPs and also for which
the company is indemnified by Goodrich. Goodrich is currently indemnifying Noveon International
for several environmental remediation projects. Goodrichs share of all of these liabilities may
increase to the extent such third parties fail to honor their obligations through February 2011.
The company believes that its environmental accruals are adequate based on currently available
information. The company believes that it is reasonably possible that $4.4 million in additional
costs may be incurred at certain locations beyond the amounts accrued as a result of new
information, newly discovered conditions, changes in remediation standards or technologies or a
change in the law. Additionally, as the indemnification from Goodrich extends through February
2011, changes in assumptions regarding when costs will be incurred may result in additional
expenses to the company. Additional costs in excess of $4.4 million cannot currently be estimated.
14. Guarantor and Non-Guarantor Subsidiary Information
The repayment of the unsecured senior notes, debentures and bank term loans is unconditionally
guaranteed on a joint and several basis by the company and its direct and indirect, wholly owned,
domestic subsidiaries. The following supplemental condensed consolidating financial information
presents the companys statements of income for the three
-20-
THE LUBRIZOL CORPORATION
Notes to Consolidated Financial Statements
September 30, 2005
and nine months ended September 30, 2005
and 2004, its balance sheets as of September 30, 2005 and December 31, 2004 and its statements of
cash flow for the nine months ended September 30, 2005 and 2004. The elimination of intercompany
profit in inventory as of the respective balance sheet date is reflected in the eliminations
columns of the condensed consolidating financial information.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Condensed Consolidating Statement of Income |
|
|
|
Three Months Ended September 30, 2005 |
|
|
|
Parent |
|
|
Subsidiary |
|
|
Other |
|
|
|
|
|
|
Total |
|
(in millions of dollars) |
|
Company |
|
|
Guarantors |
|
|
Subsidiaries |
|
|
Eliminations |
|
|
Consolidated |
|
Net sales |
|
$ |
335.5 |
|
|
$ |
328.7 |
|
|
$ |
497.0 |
|
|
$ |
(147.8 |
) |
|
$ |
1,013.4 |
|
Royalties and other revenues |
|
|
0.6 |
|
|
|
0.1 |
|
|
|
|
|
|
|
|
|
|
|
0.7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues |
|
|
336.1 |
|
|
|
328.8 |
|
|
|
497.0 |
|
|
|
(147.8 |
) |
|
|
1,014.1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of sales |
|
|
268.5 |
|
|
|
256.4 |
|
|
|
388.3 |
|
|
|
(147.8 |
) |
|
|
765.4 |
|
Selling and administrative expenses |
|
|
38.2 |
|
|
|
29.9 |
|
|
|
25.0 |
|
|
|
|
|
|
|
93.1 |
|
Research, testing and development
expenses |
|
|
22.4 |
|
|
|
9.6 |
|
|
|
17.9 |
|
|
|
|
|
|
|
49.9 |
|
Amortization of intangible assets |
|
|
0.7 |
|
|
|
4.0 |
|
|
|
1.6 |
|
|
|
|
|
|
|
6.3 |
|
Restructuring and impairment charges |
|
|
|
|
|
|
|
|
|
|
7.4 |
|
|
|
|
|
|
|
7.4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total costs and expenses |
|
|
329.8 |
|
|
|
299.9 |
|
|
|
440.2 |
|
|
|
(147.8 |
) |
|
|
922.1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other income
(expense) net |
|
|
5.7 |
|
|
|
8.3 |
|
|
|
(15.0 |
) |
|
|
0.2 |
|
|
|
(0.8 |
) |
Interest
(expense) income net |
|
|
(26.0 |
) |
|
|
|
|
|
|
0.9 |
|
|
|
|
|
|
|
(25.1 |
) |
Equity in income of subsidiaries |
|
|
60.0 |
|
|
|
14.7 |
|
|
|
|
|
|
|
(74.7 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
before income taxes |
|
|
46.0 |
|
|
|
51.9 |
|
|
|
42.7 |
|
|
|
(74.5 |
) |
|
|
66.1 |
|
Provision (benefit) for income taxes |
|
|
(2.6 |
) |
|
|
11.8 |
|
|
|
12.1 |
|
|
|
|
|
|
|
21.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations |
|
|
48.6 |
|
|
|
40.1 |
|
|
|
30.6 |
|
|
|
(74.5 |
) |
|
|
44.8 |
|
Discontinued operations net of tax |
|
|
|
|
|
|
2.8 |
|
|
|
1.0 |
|
|
|
|
|
|
|
3.8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
48.6 |
|
|
$ |
42.9 |
|
|
$ |
31.6 |
|
|
$ |
(74.5 |
) |
|
$ |
48.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
-21-
THE LUBRIZOL CORPORATION
Notes to Consolidated Financial Statements
September 30, 2005
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Condensed Consolidating Statement of Income |
|
|
|
Nine Months Ended September 30, 2005 |
|
|
|
Parent |
|
|
Subsidiary |
|
|
Other |
|
|
|
|
|
|
Total |
|
(in millions of dollars) |
|
Company |
|
|
Guarantors |
|
|
Subsidiaries |
|
|
Eliminations |
|
|
Consolidated |
|
Net sales |
|
$ |
997.4 |
|
|
$ |
980.5 |
|
|
$ |
1,500.9 |
|
|
$ |
(443.0 |
) |
|
$ |
3,035.8 |
|
Royalties and other revenues |
|
|
1.9 |
|
|
|
0.2 |
|
|
|
0.1 |
|
|
|
|
|
|
|
2.2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues |
|
|
999.3 |
|
|
|
980.7 |
|
|
|
1,501.0 |
|
|
|
(443.0 |
) |
|
|
3,038.0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of sales |
|
|
790.9 |
|
|
|
763.3 |
|
|
|
1,156.4 |
|
|
|
(443.0 |
) |
|
|
2,267.6 |
|
Selling and administrative expenses |
|
|
111.4 |
|
|
|
88.2 |
|
|
|
79.1 |
|
|
|
|
|
|
|
278.7 |
|
Research, testing and development
expenses |
|
|
68.4 |
|
|
|
29.4 |
|
|
|
53.2 |
|
|
|
|
|
|
|
151.0 |
|
Amortization of intangible assets |
|
|
2.2 |
|
|
|
12.1 |
|
|
|
4.6 |
|
|
|
|
|
|
|
18.9 |
|
Restructuring and impairment charges |
|
|
4.7 |
|
|
|
2.6 |
|
|
|
11.6 |
|
|
|
|
|
|
|
18.9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total costs and expenses |
|
|
977.6 |
|
|
|
895.6 |
|
|
|
1,304.9 |
|
|
|
(443.0 |
) |
|
|
2,735.1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other income
(expense) net |
|
|
20.4 |
|
|
|
15.1 |
|
|
|
(33.3 |
) |
|
|
(1.3 |
) |
|
|
0.9 |
|
Interest
(expense) income net |
|
|
(78.1 |
) |
|
|
(1.0 |
) |
|
|
4.7 |
|
|
|
|
|
|
|
(74.4 |
) |
Equity in income of subsidiaries |
|
|
191.9 |
|
|
|
59.9 |
|
|
|
|
|
|
|
(251.8 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
before income taxes |
|
|
155.9 |
|
|
|
159.1 |
|
|
|
167.5 |
|
|
|
(253.1 |
) |
|
|
229.4 |
|
Provision (benefit) for income taxes |
|
|
(1.5 |
) |
|
|
34.2 |
|
|
|
44.4 |
|
|
|
|
|
|
|
77.1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations |
|
|
157.4 |
|
|
|
124.9 |
|
|
|
123.1 |
|
|
|
(253.1 |
) |
|
|
152.3 |
|
Discontinued operations net of tax |
|
|
(0.2 |
) |
|
|
3.3 |
|
|
|
1.8 |
|
|
|
|
|
|
|
4.9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
157.2 |
|
|
$ |
128.2 |
|
|
$ |
124.9 |
|
|
$ |
(253.1 |
) |
|
$ |
157.2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
-22-
THE LUBRIZOL CORPORATION
Notes to Consolidated Financial Statements
September 30, 2005
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Condensed Consolidating Statement of Income |
|
|
|
Three Months Ended September 30, 2004 |
|
|
|
Parent |
|
|
Subsidiary |
|
|
Other |
|
|
|
|
|
|
Total |
|
(in millions of dollars) |
|
Company |
|
|
Guarantors |
|
|
Subsidiaries |
|
|
Eliminations |
|
|
Consolidated |
|
Net sales |
|
$ |
308.6 |
|
|
$ |
305.7 |
|
|
$ |
440.8 |
|
|
$ |
(139.2 |
) |
|
$ |
915.9 |
|
Royalties and other revenues |
|
|
0.9 |
|
|
|
0.3 |
|
|
|
|
|
|
|
|
|
|
|
1.2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues |
|
|
309.5 |
|
|
|
306.0 |
|
|
|
440.8 |
|
|
|
(139.2 |
) |
|
|
917.1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of sales |
|
|
236.4 |
|
|
|
251.7 |
|
|
|
339.6 |
|
|
|
(139.2 |
) |
|
|
688.5 |
|
Selling and administrative expenses |
|
|
36.1 |
|
|
|
19.9 |
|
|
|
30.7 |
|
|
|
|
|
|
|
86.7 |
|
Research, testing and development
expenses |
|
|
24.8 |
|
|
|
13.5 |
|
|
|
12.7 |
|
|
|
|
|
|
|
51.0 |
|
Amortization of intangible assets |
|
|
0.7 |
|
|
|
3.8 |
|
|
|
0.5 |
|
|
|
|
|
|
|
5.0 |
|
Credit for acquired
in-process research and development |
|
|
|
|
|
|
(1.5 |
) |
|
|
|
|
|
|
|
|
|
|
(1.5 |
) |
Restructuring and impairment charges |
|
|
8.4 |
|
|
|
0.2 |
|
|
|
1.9 |
|
|
|
|
|
|
|
10.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total costs and expenses |
|
|
306.4 |
|
|
|
287.6 |
|
|
|
385.4 |
|
|
|
(139.2 |
) |
|
|
840.2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other income
(expense) net |
|
|
8.3 |
|
|
|
3.3 |
|
|
|
(10.9 |
) |
|
|
(0.5 |
) |
|
|
0.2 |
|
Interest (expense) income net |
|
|
(27.4 |
) |
|
|
0.8 |
|
|
|
0.5 |
|
|
|
|
|
|
|
(26.1 |
) |
Equity in income of subsidiaries |
|
|
45.4 |
|
|
|
15.3 |
|
|
|
|
|
|
|
(60.7 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
before income taxes |
|
|
29.4 |
|
|
|
37.8 |
|
|
|
45.0 |
|
|
|
(61.2 |
) |
|
|
51.0 |
|
Provision (benefit) for income taxes |
|
|
(2.8 |
) |
|
|
0.1 |
|
|
|
22.3 |
|
|
|
|
|
|
|
19.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations |
|
|
32.2 |
|
|
|
37.7 |
|
|
|
22.7 |
|
|
|
(61.2 |
) |
|
|
31.4 |
|
Discontinued operations net of tax |
|
|
|
|
|
|
0.2 |
|
|
|
0.6 |
|
|
|
|
|
|
|
0.8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
32.2 |
|
|
$ |
37.9 |
|
|
$ |
23.3 |
|
|
$ |
(61.2 |
) |
|
$ |
32.2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
-23-
THE LUBRIZOL CORPORATION
Notes to Consolidated Financial Statements
September 30, 2005
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Condensed Consolidating Statement of Income |
|
|
|
Nine Months Ended September 30, 2004 |
|
|
|
Parent |
|
|
Subsidiary |
|
|
Other |
|
|
|
|
|
|
Total |
|
(in millions of dollars) |
|
Company |
|
|
Guarantors |
|
|
Subsidiaries |
|
|
Eliminations |
|
|
Consolidated |
|
Net sales |
|
$ |
924.3 |
|
|
$ |
500.6 |
|
|
$ |
1,119.7 |
|
|
$ |
(336.8 |
) |
|
$ |
2,207.8 |
|
Royalties and other revenues |
|
|
2.6 |
|
|
|
0.7 |
|
|
|
0.1 |
|
|
|
|
|
|
|
3.4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues |
|
|
926.9 |
|
|
|
501.3 |
|
|
|
1,119.8 |
|
|
|
(336.8 |
) |
|
|
2,211.2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of sales |
|
|
688.8 |
|
|
|
405.7 |
|
|
|
882.4 |
|
|
|
(336.8 |
) |
|
|
1,640.1 |
|
Selling and administrative expenses |
|
|
108.9 |
|
|
|
35.6 |
|
|
|
62.7 |
|
|
|
|
|
|
|
207.2 |
|
Research, testing and development
expenses |
|
|
79.9 |
|
|
|
20.3 |
|
|
|
36.7 |
|
|
|
|
|
|
|
136.9 |
|
Amortization of intangible assets |
|
|
2.2 |
|
|
|
7.4 |
|
|
|
1.8 |
|
|
|
|
|
|
|
11.4 |
|
Write-off of acquired
in-process research and development |
|
|
|
|
|
|
33.5 |
|
|
|
|
|
|
|
|
|
|
|
33.5 |
|
Restructuring and impairment charges |
|
|
14.1 |
|
|
|
0.2 |
|
|
|
3.6 |
|
|
|
|
|
|
|
17.9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total costs and expenses |
|
|
893.9 |
|
|
|
502.7 |
|
|
|
987.2 |
|
|
|
(336.8 |
) |
|
|
2,047.0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other
income (expense)
net |
|
|
28.1 |
|
|
|
10.0 |
|
|
|
(33.8 |
) |
|
|
(1.8 |
) |
|
|
2.5 |
|
Interest (expense) income net |
|
|
(47.0 |
) |
|
|
(2.5 |
) |
|
|
1.0 |
|
|
|
|
|
|
|
(48.5 |
) |
Equity in income of subsidiaries |
|
|
66.8 |
|
|
|
23.7 |
|
|
|
|
|
|
|
(90.5 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
before income taxes |
|
|
80.9 |
|
|
|
29.8 |
|
|
|
99.8 |
|
|
|
(92.3 |
) |
|
|
118.2 |
|
Provision for income taxes |
|
|
7.3 |
|
|
|
0.2 |
|
|
|
37.6 |
|
|
|
|
|
|
|
45.1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations |
|
|
73.6 |
|
|
|
29.6 |
|
|
|
62.2 |
|
|
|
(92.3 |
) |
|
|
73.1 |
|
Discontinued operations net of tax |
|
|
|
|
|
|
(0.3 |
) |
|
|
0.8 |
|
|
|
|
|
|
|
0.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
73.6 |
|
|
$ |
29.3 |
|
|
$ |
63.0 |
|
|
$ |
(92.3 |
) |
|
$ |
73.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
-24-
THE LUBRIZOL CORPORATION
Notes to Consolidated Financial Statements
September 30, 2005
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Condensed Consolidating Balance Sheet |
|
|
|
September 30, 2005 |
|
|
|
Parent |
|
|
Subsidiary |
|
|
Other |
|
|
|
|
|
|
Total |
|
(in millions of dollars) |
|
Company |
|
|
Guarantors |
|
|
Subsidiaries |
|
|
Eliminations |
|
|
Consolidated |
|
ASSETS |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and short-term investments |
|
$ |
94.2 |
|
|
$ |
9.2 |
|
|
$ |
149.5 |
|
|
$ |
|
|
|
$ |
252.9 |
|
Receivables
net |
|
|
137.7 |
|
|
|
147.9 |
|
|
|
334.7 |
|
|
|
|
|
|
|
620.3 |
|
Inventories |
|
|
99.9 |
|
|
|
175.4 |
|
|
|
316.2 |
|
|
|
(31.6 |
) |
|
|
559.9 |
|
Other current assets |
|
|
73.5 |
|
|
|
20.0 |
|
|
|
8.7 |
|
|
|
10.6 |
|
|
|
112.8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current assets |
|
|
405.3 |
|
|
|
352.5 |
|
|
|
809.1 |
|
|
|
(21.0 |
) |
|
|
1,545.9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Property and
equipment net |
|
|
385.7 |
|
|
|
451.6 |
|
|
|
348.7 |
|
|
|
|
|
|
|
1,186.0 |
|
Goodwill |
|
|
27.1 |
|
|
|
676.4 |
|
|
|
441.0 |
|
|
|
|
|
|
|
1,144.5 |
|
Intangible assets net |
|
|
10.2 |
|
|
|
273.9 |
|
|
|
127.9 |
|
|
|
|
|
|
|
412.0 |
|
Investments in subsidiaries
and intercompany balances |
|
|
2,645.7 |
|
|
|
1,849.9 |
|
|
|
579.5 |
|
|
|
(5,075.1 |
) |
|
|
|
|
Investments in non-consolidated
companies |
|
|
6.6 |
|
|
|
1.4 |
|
|
|
|
|
|
|
|
|
|
|
8.0 |
|
Other assets |
|
|
33.7 |
|
|
|
2.5 |
|
|
|
15.5 |
|
|
|
|
|
|
|
51.7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL |
|
$ |
3,514.3 |
|
|
$ |
3,608.2 |
|
|
$ |
2,321.7 |
|
|
$ |
(5,096.1 |
) |
|
$ |
4,348.1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND SHAREHOLDERS
EQUITY |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Short-term debt and current
portion of long-term debt |
|
$ |
|
|
|
$ |
0.1 |
|
|
$ |
2.9 |
|
|
$ |
|
|
|
$ |
3.0 |
|
Accounts payable |
|
|
111.0 |
|
|
|
88.7 |
|
|
|
110.4 |
|
|
|
|
|
|
|
310.1 |
|
Accrued expenses and other
current liabilities |
|
|
117.7 |
|
|
|
105.8 |
|
|
|
122.9 |
|
|
|
|
|
|
|
346.4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current liabilities |
|
|
228.7 |
|
|
|
194.6 |
|
|
|
236.2 |
|
|
|
|
|
|
|
659.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Long-term debt |
|
|
1,472.8 |
|
|
|
0.1 |
|
|
|
216.7 |
|
|
|
|
|
|
|
1,689.6 |
|
Postretirement health-care
obligations |
|
|
95.0 |
|
|
|
4.4 |
|
|
|
6.5 |
|
|
|
|
|
|
|
105.9 |
|
Noncurrent liabilities |
|
|
56.7 |
|
|
|
44.5 |
|
|
|
81.2 |
|
|
|
|
|
|
|
182.4 |
|
Deferred income taxes |
|
|
65.7 |
|
|
|
(8.9 |
) |
|
|
26.5 |
|
|
|
|
|
|
|
83.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities |
|
|
1,918.9 |
|
|
|
234.7 |
|
|
|
567.1 |
|
|
|
|
|
|
|
2,720.7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Minority interest in consolidated
companies |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
53.0 |
|
|
|
53.0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total shareholders equity |
|
|
1,595.4 |
|
|
|
3,373.5 |
|
|
|
1,754.6 |
|
|
|
(5,149.1 |
) |
|
|
1,574.4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL |
|
$ |
3,514.3 |
|
|
$ |
3,608.2 |
|
|
$ |
2,321.7 |
|
|
$ |
(5,096.1 |
) |
|
$ |
4,348.1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
-25-
THE LUBRIZOL CORPORATION
Notes to Consolidated Financial Statements
September 30, 2005
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Condensed Consolidating Balance Sheet |
|
|
|
December 31, 2004 |
|
|
|
Parent |
|
|
Subsidiary |
|
|
Other |
|
|
|
|
|
|
Total |
|
(in millions of dollars) |
|
Company |
|
|
Guarantors |
|
|
Subsidiaries |
|
|
Eliminations |
|
|
Consolidated |
|
ASSETS |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and short-term investments |
|
$ |
40.3 |
|
|
$ |
(0.1 |
) |
|
$ |
295.7 |
|
|
$ |
|
|
|
$ |
335.9 |
|
Receivables
net |
|
|
128.3 |
|
|
|
158.9 |
|
|
|
295.6 |
|
|
|
|
|
|
|
582.8 |
|
Inventories |
|
|
115.7 |
|
|
|
174.3 |
|
|
|
309.6 |
|
|
|
(30.9 |
) |
|
|
568.7 |
|
Other current assets |
|
|
67.7 |
|
|
|
20.7 |
|
|
|
11.6 |
|
|
|
10.6 |
|
|
|
110.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current assets |
|
|
352.0 |
|
|
|
353.8 |
|
|
|
912.5 |
|
|
|
(20.3 |
) |
|
|
1,598.0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Property and
equipment net |
|
|
401.0 |
|
|
|
498.3 |
|
|
|
418.6 |
|
|
|
|
|
|
|
1,317.9 |
|
Goodwill |
|
|
27.1 |
|
|
|
633.1 |
|
|
|
493.6 |
|
|
|
|
|
|
|
1,153.8 |
|
Intangible
assets net |
|
|
11.4 |
|
|
|
286.1 |
|
|
|
139.6 |
|
|
|
|
|
|
|
437.1 |
|
Investments in subsidiaries
and intercompany balances |
|
|
3,087.0 |
|
|
|
1,625.9 |
|
|
|
(238.0 |
) |
|
|
(4,474.9 |
) |
|
|
|
|
Investments in non-consolidated
companies |
|
|
5.7 |
|
|
|
1.7 |
|
|
|
|
|
|
|
|
|
|
|
7.4 |
|
Other assets |
|
|
33.6 |
|
|
|
5.5 |
|
|
|
13.0 |
|
|
|
|
|
|
|
52.1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL |
|
$ |
3,917.8 |
|
|
$ |
3,404.4 |
|
|
$ |
1,739.3 |
|
|
$ |
(4,495.2 |
) |
|
$ |
4,566.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND SHAREHOLDERS
EQUITY |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Short-term debt and current
portion of long-term debt |
|
$ |
|
|
|
$ |
|
|
|
$ |
8.2 |
|
|
$ |
|
|
|
$ |
8.2 |
|
Accounts payable |
|
|
118.3 |
|
|
|
99.4 |
|
|
|
121.9 |
|
|
|
|
|
|
|
339.6 |
|
Accrued expenses and other
current liabilities |
|
|
145.0 |
|
|
|
54.8 |
|
|
|
109.7 |
|
|
|
|
|
|
|
309.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current liabilities |
|
|
263.3 |
|
|
|
154.2 |
|
|
|
239.8 |
|
|
|
|
|
|
|
657.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Long-term debt |
|
|
1,957.2 |
|
|
|
|
|
|
|
6.9 |
|
|
|
|
|
|
|
1,964.1 |
|
Postretirement health-care
obligations |
|
|
96.3 |
|
|
|
3.9 |
|
|
|
6.2 |
|
|
|
|
|
|
|
106.4 |
|
Noncurrent liabilities |
|
|
47.5 |
|
|
|
40.5 |
|
|
|
82.7 |
|
|
|
|
|
|
|
170.7 |
|
Deferred income taxes |
|
|
16.0 |
|
|
|
41.7 |
|
|
|
33.0 |
|
|
|
|
|
|
|
90.7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities |
|
|
2,380.3 |
|
|
|
240.3 |
|
|
|
368.6 |
|
|
|
|
|
|
|
2,989.2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Minority interest in consolidated
companies |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
53.6 |
|
|
|
53.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total shareholders equity |
|
|
1,537.5 |
|
|
|
3,164.1 |
|
|
|
1,370.7 |
|
|
|
(4,548.8 |
) |
|
|
1,523.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL |
|
$ |
3,917.8 |
|
|
$ |
3,404.4 |
|
|
$ |
1,739.3 |
|
|
$ |
(4,495.2 |
) |
|
$ |
4,566.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
-26-
THE LUBRIZOL CORPORATION
Notes to Consolidated Financial Statements
September 30, 2005
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Condensed Consolidating Statement of Cash Flows |
|
|
|
Nine Months Ended September 30, 2005 |
|
|
|
Parent |
|
|
Subsidiary |
|
|
Other |
|
|
|
|
|
|
Total |
|
(in millions of dollars) |
|
Company |
|
|
Guarantors |
|
|
Subsidiaries |
|
|
Eliminations |
|
|
Consolidated |
|
CASH PROVIDED BY (USED FOR): |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
OPERATING ACTIVITIES: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
157.2 |
|
|
$ |
128.2 |
|
|
$ |
124.9 |
|
|
$ |
(253.1 |
) |
|
$ |
157.2 |
|
Adjustments to reconcile net income to
cash provided by
(used for) operating
activities |
|
|
102.1 |
|
|
|
41.9 |
|
|
|
(270.5 |
) |
|
|
253.1 |
|
|
|
126.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating activities |
|
|
259.3 |
|
|
|
170.1 |
|
|
|
(145.6 |
) |
|
|
|
|
|
|
283.8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
INVESTING ACTIVITIES: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital expenditures |
|
|
(30.2 |
) |
|
|
(27.1 |
) |
|
|
(34.2 |
) |
|
|
|
|
|
|
(91.5 |
) |
Net proceeds from divestitures and sales
of property and equipment |
|
|
2.1 |
|
|
|
10.1 |
|
|
|
5.0 |
|
|
|
|
|
|
|
17.2 |
|
Other items net |
|
|
(0.2 |
) |
|
|
0.1 |
|
|
|
(0.1 |
) |
|
|
|
|
|
|
(0.2 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total investing activities |
|
|
(28.3 |
) |
|
|
(16.9 |
) |
|
|
(29.3 |
) |
|
|
|
|
|
|
(74.5 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
FINANCING ACTIVITIES: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Changes in short-term debt net |
|
|
|
|
|
|
|
|
|
|
(4.9 |
) |
|
|
|
|
|
|
(4.9 |
) |
Repayments of long-term debt |
|
|
(475.0 |
) |
|
|
|
|
|
|
(0.2 |
) |
|
|
|
|
|
|
(475.2 |
) |
Long-term borrowings |
|
|
|
|
|
|
(0.4 |
) |
|
|
214.2 |
|
|
|
|
|
|
|
213.8 |
|
Dividends paid |
|
|
(52.7 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(52.7 |
) |
Changes in intercompany activities |
|
|
313.2 |
|
|
|
(146.1 |
) |
|
|
(167.1 |
) |
|
|
|
|
|
|
|
|
Proceeds from the exercise of stock
options |
|
|
37.4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
37.4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total financing activities |
|
|
(177.1 |
) |
|
|
(146.5 |
) |
|
|
42.0 |
|
|
|
|
|
|
|
(281.6 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effect of exchange rate changes on cash |
|
|
|
|
|
|
2.6 |
|
|
|
(13.3 |
) |
|
|
|
|
|
|
(10.7 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net increase (decrease) in cash and
short-term investments |
|
|
53.9 |
|
|
|
9.3 |
|
|
|
(146.2 |
) |
|
|
|
|
|
|
(83.0 |
) |
Cash and short-term investments at
beginning of period |
|
|
40.3 |
|
|
|
(0.1 |
) |
|
|
295.7 |
|
|
|
|
|
|
|
335.9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and short-term investments at
end of period |
|
$ |
94.2 |
|
|
$ |
9.2 |
|
|
$ |
149.5 |
|
|
$ |
|
|
|
$ |
252.9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
-27-
THE LUBRIZOL CORPORATION
Notes to Consolidated Financial Statements
September 30, 2005
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Condensed Consolidating Statement of Cash Flows |
|
|
|
Nine Months Ended September 30, 2004 |
|
|
|
Parent |
|
|
Subsidiary |
|
|
Other |
|
|
|
|
|
|
Total |
|
(in millions of dollars) |
|
Company |
|
|
Guarantors |
|
|
Subsidiaries |
|
|
Eliminations |
|
|
Consolidated |
|
CASH PROVIDED BY (USED FOR): |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
OPERATING ACTIVITIES: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
73.6 |
|
|
$ |
29.3 |
|
|
$ |
63.0 |
|
|
$ |
(92.3 |
) |
|
$ |
73.6 |
|
Adjustments to reconcile net income to
cash provided by (used
for) operating
activities |
|
|
(6.4 |
) |
|
|
(33.3 |
) |
|
|
66.4 |
|
|
|
92.3 |
|
|
|
119.0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating activities |
|
|
67.2 |
|
|
|
(4.0 |
) |
|
|
129.4 |
|
|
|
|
|
|
|
192.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
INVESTING ACTIVITIES: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital expenditures |
|
|
(39.7 |
) |
|
|
(19.5 |
) |
|
|
(23.2 |
) |
|
|
|
|
|
|
(82.4 |
) |
Acquisitions
net of cash received
and liabilities assumed |
|
|
(3.6 |
) |
|
|
(828.4 |
) |
|
|
(126.2 |
) |
|
|
|
|
|
|
(958.2 |
) |
Net proceeds
from sale of property and equipment |
|
|
0.6 |
|
|
|
|
|
|
|
1.3 |
|
|
|
|
|
|
|
1.9 |
|
Other items net |
|
|
(0.5 |
) |
|
|
0.1 |
|
|
|
|
|
|
|
|
|
|
|
(0.4 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total investing activities |
|
|
(43.2 |
) |
|
|
(847.8 |
) |
|
|
(148.1 |
) |
|
|
|
|
|
|
(1,039.1 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
FINANCING ACTIVITIES: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Changes in short-term debt net |
|
|
|
|
|
|
(78.3 |
) |
|
|
8.6 |
|
|
|
|
|
|
|
(69.7 |
) |
Repayments of long-term debt |
|
|
(93.4 |
) |
|
|
(1,024.6 |
) |
|
|
|
|
|
|
|
|
|
|
(1,118.0 |
) |
Long-term borrowings |
|
|
1,741.7 |
|
|
|
|
|
|
|
1.5 |
|
|
|
|
|
|
|
1,743.2 |
|
Dividends paid |
|
|
(40.3 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(40.3 |
) |
Changes in intercompany activities |
|
|
(2,006.9 |
) |
|
|
1,966.0 |
|
|
|
40.9 |
|
|
|
|
|
|
|
|
|
Proceeds from sale of common shares |
|
|
427.2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
427.2 |
|
Payment of debt issuance costs |
|
|
(16.8 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(16.8 |
) |
Payment of treasury rate lock settlement |
|
|
(73.9 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(73.9 |
) |
Proceeds from the exercise of stock
options |
|
|
12.8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12.8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total financing activities |
|
|
(49.6 |
) |
|
|
863.1 |
|
|
|
51.0 |
|
|
|
|
|
|
|
864.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effect of exchange rate changes on cash |
|
|
6.4 |
|
|
|
(0.8 |
) |
|
|
1.8 |
|
|
|
|
|
|
|
7.4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net (decrease) increase in cash and
short-term investments |
|
|
(19.2 |
) |
|
|
10.5 |
|
|
|
34.1 |
|
|
|
|
|
|
|
25.4 |
|
Cash and short-term investments at
beginning of period |
|
|
56.2 |
|
|
|
(1.0 |
) |
|
|
203.5 |
|
|
|
|
|
|
|
258.7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and short-term investments at
end of period |
|
$ |
37.0 |
|
|
$ |
9.5 |
|
|
$ |
237.6 |
|
|
$ |
|
|
|
$ |
284.1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
-28-
Item 2.
Managements Discussion and Analysis of Financial Condition and
Results of Operations
This Managements Discussion and Analysis of Financial Condition and Results of Operations should
be read in conjunction with the unaudited consolidated financial statements and the notes thereto
appearing elsewhere in this quarterly report on Form 10-Q. Historical results and percentage
relationships set forth in the consolidated financial statements, including trends that might
appear, should not be taken as indicative of future operations. The following discussion contains
forward-looking statements that involve risk and uncertainties. Our actual results may differ
materially from those discussed in such forward-looking statements as a result of various factors,
including those described under the section Cautionary Statements for Safe Harbor Purposes
included elsewhere in this quarterly report on Form 10-Q.
OVERVIEW
We are an innovative specialty chemical company that produces and supplies technologies that
improve the quality and performance of our customers products in the global transportation,
industrial and consumer markets. Our business is founded on technological leadership. Innovation
provides opportunities for us in growth markets as well as advantages over our competitors. From a
base of approximately 2,100 patents, we use our product development and formulation expertise to
sustain our leading market positions and fuel our future growth. We create additives, ingredients,
resins and compounds that enhance the performance, quality and value of our customers products,
while minimizing their environmental impact. Our products are used in a broad range of
applications, and are sold into stable markets such as those for engine oils, specialty driveline
lubricants and metalworking fluids, as well as higher-growth markets such as personal care and
pharmaceutical products and performance coatings and inks. Our specialty materials products are
also used in a variety of industries, including the construction, sporting goods, medical products
and automotive industries. We are an industry leader in the majority of our product lines.
We are geographically diverse, with an extensive global manufacturing, supply chain, technical and
commercial infrastructure. We operate facilities in 27 countries, comprised of production
facilities in 21 countries and laboratories in 11 countries, through the efforts of more than 7,600
employees. We sell our products in more than 100 countries and believe that our customers value
our ability to provide customized, high-quality, cost-effective performance formulations and
solutions worldwide. We also believe that our customers value our global supply chain
capabilities.
In September 2005, we sold certain assets and liabilities of our U.S. and U.K. Lubrizol Performance
Systems (LPS) operations, which were included in the Lubricant Additives segment. We have
reflected the results of the LPS business as a discontinued operation in the consolidated
statements of income for all periods presented. Accordingly, historical consolidated statements of
income amounts included in Managements Discussion and Analysis of Financial Condition and Results
of Operations have been restated to reflect the discontinued operation. We recorded a gain on sale
of discontinued operations of $4.2 million ($2.9 million net of tax), in the third quarter of 2005.
On June 3, 2004, we completed the acquisition of Noveon International, Inc. (Noveon International),
a leading global producer and marketer of technologically advanced specialty materials and
chemicals used in the industrial and consumer markets. With the acquisition of Noveon
International, we have accelerated our program to attain a substantial presence in the personal
care and coatings markets by adding a number of higher-growth, industry-leading products under
highly recognizable brand names, including
Carbopol®, to our already strong portfolio
of lubricant and fuel additives, and consumer products. Additionally, Noveon International has a
number of industry-leading and strong, cash flow-generating specialty materials businesses,
including TempRite® chlorinated polyvinyl chloride
(CPVC) and Estane®
thermoplastic polyurethane (TPU).
We acquired Noveon International for cash of $920.2 million (inclusive of certain seller expenses
of $32.9 million) plus transaction costs of $11.4 million and less cash acquired of $103.0 million.
In addition, we assumed $1,103.1 million of long-term indebtedness from Noveon International.
-29-
Item 2.
Managements Discussion and Analysis of Financial Condition and
Results of Operations (continued)
We initially financed the acquisition and related costs with the proceeds of a $2,450.0 million
364-day bridge credit facility. Shortly after the acquisition, we repaid substantially all of the
assumed long-term debt with proceeds of the temporary bridge loan. In addition, we repaid the
temporary bridge loan in full in September 2004 when we secured our permanent financing that
included the issuance of senior notes, debentures, bank term loans and equity.
Our consolidated balance sheets as of September 30, 2005 and December 31, 2004 reflect the
acquisition of Noveon International under the purchase method of accounting. We recorded the
various assets acquired and liabilities assumed, primarily working capital accounts, of Noveon
International at their estimated fair values determined as of the acquisition date. Actuarial
valuations were completed for the projected pension and other post-employment benefit obligations
and were reflected in the purchase price allocation. We also obtained appraisals of long-lived
assets and identifiable intangible assets, including an evaluation of in-process research and
development (IPR&D) projects. Through June 2005, we finalized certain aspects of the purchase
price allocation primarily surrounding the valuation of the property, plant and equipment and the
deferred tax accounts. In connection with the acquisition of Noveon International, we have
targeted non-core businesses with total revenues of approximately $500.0 million for disposition.
This plan was contemplated at the time of acquisition and plan activities have been underway since
the fourth quarter of 2004. In addition, through June 2005, we continued the process of finalizing
the reconciliation of the underlying fixed-asset records to the respective appraisals. As a result
of both of these efforts, in the six months ended June 30, 2005, we reduced the amount allocated to
property, plant and equipment by $55.2 million since December 31, 2004. Depreciation expense for
the three and six months ended June 30, 2005 included a related adjustment of $1.1 million and $2.3
million, respectively, representing the change in depreciation expense associated with the change
in the estimated fair values assigned to property, plant and equipment. In addition, the deferred
tax accounts were adjusted in June 2005 resulting in a decrease of $17.7 million to the net
deferred tax liabilities since December 31, 2004. The goodwill associated with the transaction
increased by $33.7 million in the six months ended June 30, 2005 representing the net impact of all
adjustments recorded. The allocation of the purchase price was complete as of June 30, 2005 and
the related actuarial valuations and appraisals obtained have been finalized.
The purchase price included the estimated fair value of IPR&D projects totaling $34.0 million that,
as of the acquisition date, had not yet reached technological feasibility and had no alternative
future use. As a result, the full amount allocated to IPR&D was expensed in 2004. The amount
charged to expense in the second quarter of 2004 was $35.0 million, of which $1.5 million was
reversed in the third quarter of 2004. This amount was subsequently adjusted to $34.0 million in
the fourth quarter of 2004. There were no changes to the valuation of IPR&D in 2005. The
inventory step-up to fair value totaled $24.2 million, of which $4.9 million was expensed in each
of the second and third quarters of 2004. As the remaining step-up relates to inventories
accounted for on the LIFO method of accounting, we do not anticipate that additional amounts of
step-up will be expensed in the near term.
In 2005, we have continued to integrate the Noveon International acquisition ahead of schedule. We
are projecting to realize savings of approximately $40.0 million by the end of 2005, which is two
years ahead of schedule. In addition, we believe we are currently saving at an annual run-rate of
approximately $45.0 million as compared to our original run-rate target of $40.0 million.
In conjunction with the integration of Noveon International, we have also made progress in our plan
to divest non-core businesses. Negotiations are in progress for three small businesses that are
targeted for divestiture. Together, with the already completed sale of LPS, these four businesses
have revenues of approximately $100 million. Management presentations have been completed for the
largest divestiture, consisting of $400 million in revenues, and the due diligence phase is
underway. We do not believe the businesses or assets we are evaluating are considered held for
sale pursuant to the provisions of SFAS No. 144, Accounting for the Impairment or Disposal of
Long-Lived Assets, as of September 30, 2005.
-30-
Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations (continued)
RESULTS OF OPERATIONS
Our net income for the three months ended September 30, 2005 primarily increased over the
prior-year third quarter as improved price and product mix more than offset higher raw material and
energy costs. The increase in net income for the nine months ended September 30, 2005 as compared
to the prior-year nine-month period was due in part to the significant non-recurring charges
associated with the Noveon International purchase accounting that included the write-off of IPR&D
of $33.5 million and inventory step-up amortization of $9.8 million partially offset by a gain on a
foreign currency forward contract of $6.4 million. Excluding the impact associated with the Noveon
International acquisition, the related purchase accounting and the currency forward contract, the
increase in net income for the first nine months of the year primarily was attributed to improved
price and product mix, favorable currency, and a lower tax rate that more than offset higher raw
material and energy costs and lower shipment volumes. We recorded restructuring charges that
reduced earnings by $0.01 and $0.13 per share for the three and nine months ended September 30,
2005, respectively, primarily related to the phase-out of manufacturing facilities located in
Bromborough, United Kingdom; Linden, New Jersey; and Mountaintop, Pennsylvania and other workforce
reductions. We also recorded an impairment charge that reduced earnings by $0.06 per share for the
three and nine months ended September 30, 2005 related to one of our European facilities based on
the fair value estimates obtained in our divestiture proceedings. We incurred a restructuring
charge of $0.13 and $0.22 per share in the three and nine months ended September 30, 2004,
respectively, primarily related to the restructuring initiated after the acquisition of Noveon
International.
During the third quarter of 2005, Hurricane Rita bypassed our two Houston-area manufacturing
facilities without causing significant damage and repair costs. The plants were shut down briefly
in preparation for the storm. As a result, we realized an unfavorable impact of approximately $6.0
million related to the hurricane-related interruptions for the three-month period. This consisted
of approximately $3.0 million of gross profit associated with delayed customer shipments and $3.0
million of higher manufacturing costs primarily related to manufacturing variances attributed to
the temporary shutdown of the facilities that were appropriately expensed in the period rather than
capitalized into inventory. Both facilities returned to normal operations within days of the
hurricane. The effects of the hurricanes are continuing to be felt by the industry and overall
tightness of supply has led to significant increases in raw material and energy costs. We have
responded to these issues with price increases in many of our product lines.
-31-
Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations (continued)
Revenues
The changes in consolidated revenues are summarized as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months
Ended |
|
|
|
|
|
|
|
|
|
September 30, |
|
|
|
|
|
|
|
(in millions of dollars) |
|
2005 |
|
|
2004 |
|
|
$ Change |
|
|
% Change |
Net sales |
|
$ |
1,013.4 |
|
|
$ |
915.9 |
|
|
$ |
97.5 |
|
|
|
11 |
% |
Royalties and other
revenues |
|
|
0.7 |
|
|
|
1.2 |
|
|
|
(0.5 |
) |
|
|
(42 |
%) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues |
|
$ |
1,014.1 |
|
|
$ |
917.1 |
|
|
$ |
97.0 |
|
|
|
11 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months
Ended |
|
|
|
|
|
|
|
|
|
|
Excluding |
|
|
September 30, |
|
|
|
|
|
|
|
|
|
|
Acquisitions |
(in millions of dollars) |
|
2005 |
|
|
2004 |
|
|
$ Change |
|
|
% Change |
|
$ Change |
|
|
% Change |
Net sales |
|
$ |
3,035.8 |
|
|
$ |
2,207.8 |
|
|
$ |
828.0 |
|
|
|
38 |
% |
|
$ |
236.8 |
|
|
|
11 |
% |
Royalties and other
revenues |
|
|
2.2 |
|
|
|
3.4 |
|
|
|
(1.2 |
) |
|
|
(35 |
%) |
|
|
(1.1 |
) |
|
|
(32 |
%) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues |
|
$ |
3,038.0 |
|
|
$ |
2,211.2 |
|
|
$ |
826.8 |
|
|
|
37 |
% |
|
$ |
235.7 |
|
|
|
11 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The acquisition of Noveon International accounted for a significant portion of the increase in
consolidated revenues for the nine months ended September 30, 2005 compared to the nine months
ended September 30, 2004. The 2004 acquisitions of Noveon International and the hyperdispersants
business purchased from Avecia contributed $591.2 million toward the increase in revenues for the
nine months ended September 30, 2005 as compared with the same period in 2004.
The increase in revenues for both the three and nine months (excluding acquisitions) ended
September 30, 2005 primarily was due to an improvement in price and product mix resulting from the
cumulative impact of a series of price increases over the past year. We also experienced favorable
currency impacts for the nine months ended September 30, 2005. As summarized in the volume tables
below, we experienced slight volume declines for the three and nine months (excluding acquisitions)
ended September 30, 2005 compared to the respective prior-year periods.
The following table shows our shipment volume by geographic zone for the three and nine months
ended September 30, 2005.
|
|
|
|
|
|
|
|
|
|
|
3rd Quarter |
|
Year-to-Date |
|
|
2005 |
|
2005 |
|
|
Volume |
|
Volume |
North America |
|
|
49 |
% |
|
|
50 |
% |
Europe |
|
|
26 |
% |
|
|
26 |
% |
Asia-Pacific / Middle East |
|
|
20 |
% |
|
|
19 |
% |
Latin America |
|
|
5 |
% |
|
|
5 |
% |
|
|
|
|
|
|
|
|
|
Total |
|
|
100 |
% |
|
|
100 |
% |
|
|
|
|
|
|
|
|
|
-32-
Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations (continued)
The following table shows the changes in our shipment volume by geographic zone as compared with
the corresponding periods in 2004.
|
|
|
|
|
|
|
2005 vs. 2004 |
|
|
% Change |
Third Quarter: |
|
|
|
|
North America |
|
|
(5 |
%) |
Europe |
|
|
(1 |
%) |
AsiaPacific / Middle East |
|
|
7 |
% |
Latin America |
|
|
(2 |
%) |
Total |
|
|
(1 |
%) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Excluding |
|
|
|
|
|
|
Acquisitions |
|
|
2005 vs. 2004 |
|
2005 vs. 2004 |
|
|
% Change |
|
% Change |
Year-to-Date: |
|
|
|
|
|
|
|
|
North America |
|
|
17 |
% |
|
|
(7 |
%) |
Europe |
|
|
11 |
% |
|
|
2 |
% |
AsiaPacific / Middle East |
|
|
16 |
% |
|
|
6 |
% |
Latin America |
|
|
6 |
% |
|
|
(6 |
%) |
Total |
|
|
15 |
% |
|
|
(2 |
%) |
Segment shipment volume variances by geographic zone as well as the factors explaining the changes
in segment revenues for both the three and nine months ended September 30, 2005 compared with the
respective periods in 2004 are contained within the Segment Analysis section below.
-33-
Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations (continued)
Costs and Expenses
The changes in consolidated costs and expenses are summarized as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
|
|
|
|
|
|
|
September 30, |
|
|
|
|
|
|
|
(in millions of dollars) |
|
2005 |
|
|
2004 |
|
|
$ Change |
|
|
% Change |
Cost of sales |
|
$ |
765.4 |
|
|
$ |
688.5 |
|
|
$ |
76.9 |
|
|
|
11 |
% |
Selling and
administrative
expenses |
|
|
93.1 |
|
|
|
86.7 |
|
|
|
6.4 |
|
|
|
7 |
% |
Research, testing and
development expenses |
|
|
49.9 |
|
|
|
51.0 |
|
|
|
(1.1 |
) |
|
|
(2 |
%) |
Amortization of
intangible assets |
|
|
6.3 |
|
|
|
5.0 |
|
|
|
1.3 |
|
|
|
* |
|
Credit for acquired
IPR&D |
|
|
|
|
|
|
(1.5 |
) |
|
|
1.5 |
|
|
|
* |
|
Restructuring and
impairment charges |
|
|
7.4 |
|
|
|
10.5 |
|
|
|
(3.1 |
) |
|
|
* |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total costs and expenses |
|
$ |
922.1 |
|
|
$ |
840.2 |
|
|
$ |
81.9 |
|
|
|
10 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended |
|
|
|
|
|
|
|
|
|
|
Excluding |
|
|
September 30, |
|
|
|
|
|
|
|
|
|
|
Acquisitions |
(in millions of dollars) |
|
2005 |
|
|
2004 |
|
|
$ Change |
|
|
% Change |
|
$ Change |
|
|
% Change |
Cost of sales |
|
$ |
2,267.6 |
|
|
$ |
1,640.1 |
|
|
$ |
627.5 |
|
|
|
38 |
% |
|
$ |
198.8 |
|
|
|
12 |
% |
Selling and
administrative
expenses |
|
|
278.7 |
|
|
|
207.2 |
|
|
|
71.5 |
|
|
|
35 |
% |
|
|
10.8 |
|
|
|
5 |
% |
Research, testing and
development expenses |
|
|
151.0 |
|
|
|
136.9 |
|
|
|
14.1 |
|
|
|
10 |
% |
|
|
(8.1 |
) |
|
|
(6 |
%) |
Amortization of
intangible assets |
|
|
18.9 |
|
|
|
11.4 |
|
|
|
7.5 |
|
|
|
* |
|
|
|
0.3 |
|
|
|
* |
|
Write-off of acquired
IPR&D |
|
|
|
|
|
|
33.5 |
|
|
|
(33.5 |
) |
|
|
* |
|
|
|
(33.5 |
) |
|
|
* |
|
Restructuring and
impairment charges |
|
|
18.9 |
|
|
|
17.9 |
|
|
|
1.0 |
|
|
|
* |
|
|
|
(0.8 |
) |
|
|
* |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total costs and expenses |
|
$ |
2,735.1 |
|
|
$ |
2,047.0 |
|
|
$ |
688.1 |
|
|
|
34 |
% |
|
$ |
167.5 |
|
|
|
8 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
Calculation not meaningful |
The increase in cost of sales for the three and nine months ended September 30, 2005 compared
with the same periods in 2004 primarily was due to higher average raw material cost and higher
utility expenses, excluding acquisitions for the nine-month period. Average raw material cost
increased 16% for the three months ended September 30, 2005 and 18%, excluding acquisitions, for
the nine months ended September 30, 2005 compared with the same periods in 2004, primarily due to
higher unit raw material cost for both periods along with unfavorable currency effects for the nine
months ended September 30, 2004. In the third quarter of 2004, we also recorded a purchase
accounting adjustment associated with the increased valuation of Noveon International-acquired
inventory of $4.9 million. Year-to-date
-34-
Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations (continued)
purchase accounting adjustments associated with the
increased valuation of Noveon International-acquired inventory
was $9.8 million for the nine months ended September 30, 2004. We expect higher raw material costs
in the fourth quarter of 2005 as compared to the third quarter of 2005.
Total manufacturing expenses, which are included in cost of sales, increased 4% for the three
months ended September 30, 2005 and 5%, excluding acquisitions, for the nine months ended September
30, 2005 compared to the respective prior year periods. Including acquisitions, total
manufacturing expenses increased 34% for the nine months ended September 30, 2005 compared to the
same period in 2004. The increase for the three months ended September 30, 2005 primarily was due
to increases in utility costs and an increase in maintenance activities, offset by a $1.6 million
environmental charge incurred in the three months ended September 30, 2004 that did not recur in
2005. We estimate that currency accounted for approximately 37% of the increase, excluding
acquisitions, for the nine months ended September 30, 2005. The remainder of the increase for the
nine-month period primarily was due to an increase in utility costs and an increase in maintenance
activities, offset by a $3.4 million environmental charge incurred in the first nine months of 2004
that did not recur in 2005. On a per-unit-sold basis, manufacturing costs increased 5% for the
three months ended September 30, 2005 and 6%, excluding acquisitions, for the nine months ended
September 30, 2005 compared to the respective prior-year periods.
Gross profit (net sales less cost of sales) increased $20.6 million, or 9.0% and $200.4 million, or
35% ($38.1 million, or 7%, excluding acquisitions) in the three and nine months ended September 30,
2005, respectively, compared with the same periods in 2004. The increase primarily was due to
higher average selling prices and improved product mix partially offset by higher average raw
material cost, manufacturing costs and lower volumes. Our gross profit percentage (gross profit
divided by net sales) decreased to 24.5% in the third quarter of 2005 compared to 24.8% in the
third quarter of 2004. The gross profit percentage decrease primarily was due to the impact of
increasing unit raw material costs compared to similar increases in per unit sales prices.
Selling and administrative expenses increased 7% for the three months ended September 30, 2005 and
5%, excluding acquisitions, for the nine months ended September 30, 2005 primarily due to higher
compensation expense. We experienced an increase in compensation-related costs due to increases in
variable compensation and annual salaries.
Research, testing and development expenses (technology expenses), decreased $1.1 million for the
three months ended September 30, 2005 and $8.1 million, excluding acquisitions, for the nine months
ended September 30, 2005 compared to the respective periods in 2004 primarily due to decreases in
salary and benefit expenses as a result of the 2004 reduction in workforce. We anticipate higher
testing expenses in the fourth quarter of 2005 as we increase testing for the next North American
diesel engine oil upgrade.
We included a one-time, non-cash charge of $33.5 million, or $0.40 per share, in total costs and
expenses for the first nine months of 2004 to write off the estimated fair value of acquired IPR&D
projects associated with the Noveon International acquisition. Approximately $35.0 million was
recorded in the second quarter of which $1.5 million, or $0.02 per share, was reversed in the third
quarter of 2004. Costs to acquire IPR&D projects that have no future alternative use and that have
not yet reached technological feasibility at the date of acquisition are expensed upon acquisition.
This amount was subsequently adjusted to $34.0 million in the fourth quarter of 2004. No further
adjustments were made in 2005 to the valuation in connection with the completion of the Noveon
International purchase accounting.
In the three and nine months ended September 30, 2005, we recorded restructuring charges
aggregating $1.2 million, or $0.01 per share, and $12.7 million, or $0.13 per share, respectively,
primarily related to the phase-out of three manufacturing facilities in both the Lubricant
Additives and Specialty Chemicals segments, as well as other workforce reductions. We also
recorded an impairment charge that reduced earnings by $6.2 million, or $0.06 per share, for the
three and nine months ended September 30, 2005 related to one of our European facilities based on
the fair value estimates obtained in our divestiture proceedings.
-35-
Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations (continued)
The components of the 2005 restructuring charges are detailed as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Periods Ended September 30, 2005 |
|
|
|
Asset |
|
|
Other Plant |
|
|
|
|
|
|
|
(in millions of dollars) |
|
Impairments |
|
|
Exit Costs |
|
|
Severance |
|
|
Total |
|
Three Months: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Coatings plant closures
and workforce reductions |
|
$ |
|
|
|
$ |
|
|
|
$ |
0.6 |
|
|
$ |
0.6 |
|
Bromborough, UK closure |
|
|
|
|
|
|
|
|
|
|
0.8 |
|
|
|
0.8 |
|
Noveon International restructuring
liabilities assumed |
|
|
|
|
|
|
|
|
|
|
(0.2 |
) |
|
|
(0.2 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
1.2 |
|
|
$ |
1.2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Coatings plant closures
and workforce reductions |
|
$ |
4.2 |
|
|
$ |
0.9 |
|
|
$ |
2.5 |
|
|
$ |
7.6 |
|
Bromborough, UK closure |
|
|
0.7 |
|
|
|
0.5 |
|
|
|
3.0 |
|
|
|
4.2 |
|
Corporate workforce reductions |
|
|
|
|
|
|
|
|
|
|
0.7 |
|
|
|
0.7 |
|
Noveon International restructuring
liabilities assumed |
|
|
|
|
|
|
|
|
|
|
0.2 |
|
|
|
0.2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
4.9 |
|
|
$ |
1.4 |
|
|
$ |
6.4 |
|
|
$ |
12.7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
In May 2005, we announced the reorganization of the Specialty Chemicals performance coatings
product line. This product line includes businesses acquired from Noveon International as well as
businesses included in the companys legacy operations. In connection with the reorganization,
management eliminated 19 positions in North America and Europe. These reductions were completed by
September 30, 2005 and resulted in a severance-related charge of $0.1 million and $1.3 million
recorded in the three and nine months ended September 30, 2005, respectively.
In the first quarter of 2005, we made the decision and the announcement to close two Specialty
Chemicals performance coatings production facilities in the United States. The aggregate
restructuring charge recorded for these closures for the three months ended September 30, 2005 was
$0.5 million, comprised primarily of severance costs. The aggregate restructuring charge recorded
for these closures for the nine months ended September 30, 2005 was $6.3 million, comprised of $4.2
million in asset impairments, $0.9 million in exit costs and $1.2 million in severance costs. We
estimate we will incur cumulative severance costs of approximately $2.1 million relating to these
closures. We recorded an impairment charge for both plants in the first quarter of 2005 to reflect
the related assets at their estimated fair values. The estimated fair value of the assets was
determined primarily from third-party appraisals. Production for these sites will be transferred
to other facilities in the United States. The facility in Mountaintop, Pennsylvania was closed in
October of 2005, while the facility in Linden, New Jersey is scheduled to close in the second
quarter of 2006. These closures will result in a workforce reduction of 62 employees by the second
quarter of 2006.
In December 2004, we made the decision to close the Lubricant Additives manufacturing facility in
Bromborough, United Kingdom. We announced this decision in January 2005. We determined, as of
December 31, 2004, that an impairment of certain of the facilitys long-lived assets had been
triggered by this decision in the fourth quarter of 2004. As a result, a $17.0 million impairment
charge was recorded in December 2004 to reflect the related assets at their estimated fair values.
The estimated fair value of the assets was determined using a discounted cash flow model.
-36-
Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations (continued)
Production phase-out of this site began in the third quarter of 2005 and is expected to be
completed by late 2006. During this phase-out, United Kingdom production will be transferred to
facilities in France and the United States.
Approximately 69 employees will be impacted by this closure. The aggregate restructuring charge
recorded for this closure for the three months ended September 30, 2005 was $0.8 million, comprised
primarily of severance costs. The aggregate restructuring charge recorded for this closure for the
nine months ended September 30, 2005 was $4.2 million, comprised of $0.7 million in asset
impairments, $0.5 million in exit costs and $3.0 million in severance costs. We currently
anticipate that pre-tax charges for cash expenditures of approximately $13.5 million to $15.5
million will be incurred in 2005 through 2007 to satisfy severance and retention obligations, plant
dismantling, site restoration and other site environmental evaluation costs and lease-related
costs, including the $4.2 million recorded through September 30, 2005.
In addition to the restructuring charges recorded for the above facilities, we also expect to
invest approximately $1.4 million relating to the two Specialty Chemicals plants and $20.0 million
related to Bromborough through the end of 2006 for capacity upgrades at alternative manufacturing
facilities that will absorb production previously undertaken at these facilities. We expect these
workforce reductions, facility closures and transfer of production to more efficient manufacturing
locations to generate annual pre-tax savings of approximately $3.2 million for Specialty Chemicals
and $10.0 million for Lubricant Additives by 2007.
In 2004, we eliminated more than 100 positions, primarily affecting technical and commercial
employees located at the Wickliffe, Ohio headquarters. Most of these workforce reductions were
related to the restructuring following the acquisition of Noveon International. These reductions
were completed by December 31, 2004. In the second quarter of 2005, we began a process of
identifying further opportunities to increase efficiency and productivity, reduce costs and support
our integration strategy of the Noveon International acquisition. As a result, we reduced
headcount in the general and administrative area of our headquarters offices in Ohio. Through
these restructuring efforts, we eliminated seven positions resulting in a severance-related charge
of $0.7 million in the nine months ended September 30, 2005. All of the affected employees had
left their positions by June 30, 2005 and the remaining personnel-related costs are expected to be
paid by 2006. We continue to evaluate other opportunities to integrate general and administrative
functions. As such opportunities are identified in future periods, we expect further restructuring
charges.
The charges for these cost reduction initiatives and impairments are reported as a separate line
item in the consolidated income statements, entitled Restructuring and impairment charges and are
included in the Total cost and expenses subtotal on the consolidated income statements.
-37-
Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations (continued)
Other Items and Net Income
The changes in other items and net income are summarized as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
|
|
|
|
September 30, |
|
|
|
|
(in millions of dollars) |
|
2005 |
|
2004 |
|
$ Change |
|
% Change |
Other income
(expense)
net |
|
$ |
(0.8 |
) |
|
$ |
0.2 |
|
|
$ |
(1.0 |
) |
|
|
* |
|
Interest
expensenet |
|
|
(25.1 |
) |
|
|
(26.1 |
) |
|
|
1.0 |
|
|
|
(4 |
%) |
Income from
continuing
operations before income
taxes |
|
|
66.1 |
|
|
|
51.0 |
|
|
|
15.1 |
|
|
|
30 |
% |
Provision for income
taxes |
|
|
21.3 |
|
|
|
19.6 |
|
|
|
1.7 |
|
|
|
9 |
% |
Income from continuing
operations |
|
|
44.8 |
|
|
|
31.4 |
|
|
|
13.4 |
|
|
|
43 |
% |
Discontinued operations |
|
|
3.8 |
|
|
|
0.8 |
|
|
|
3.0 |
|
|
|
* |
|
Net income |
|
|
48.6 |
|
|
|
32.2 |
|
|
|
16.4 |
|
|
|
51 |
% |
|
|
|
Nine Months Ended |
|
|
|
|
|
|
|
|
|
Excluding |
|
|
September 30, |
|
|
|
|
|
|
|
|
|
Acquisitions |
(in millions of dollars) |
|
2005 |
|
2004 |
|
$ Change |
|
% Change |
|
$ Change |
|
% Change |
Other income
(expense)
net |
|
$ |
0.9 |
|
|
$ |
2.5 |
|
|
$ |
(1.6 |
) |
|
|
* |
|
|
$ |
(2.3 |
) |
|
|
* |
|
Interest
expensenet |
|
|
(74.4 |
) |
|
|
(48.5 |
) |
|
|
(25.9 |
) |
|
|
* |
|
|
|
7.6 |
|
|
|
* |
|
Income from continuing
operations before income
taxes |
|
|
229.4 |
|
|
|
118.2 |
|
|
|
111.2 |
|
|
|
94 |
% |
|
|
73.5 |
|
|
|
62 |
% |
Provision for income
taxes |
|
|
77.1 |
|
|
|
45.1 |
|
|
|
32.0 |
|
|
|
71 |
% |
|
|
19.1 |
|
|
|
42 |
% |
Income from continuing
operations |
|
|
152.3 |
|
|
|
73.1 |
|
|
|
79.2 |
|
|
|
108 |
% |
|
|
54.4 |
|
|
|
74 |
% |
Discontinued operations |
|
|
4.9 |
|
|
|
0.5 |
|
|
|
4.4 |
|
|
|
* |
|
|
|
4.4 |
|
|
|
* |
|
Net income |
|
|
157.2 |
|
|
|
73.6 |
|
|
|
83.6 |
|
|
|
114 |
% |
|
|
58.8 |
|
|
|
80 |
% |
|
|
* |
Calculation not meaningful |
The changes in net other income (expense) for the three and nine months ended September 30,
2005, respectively, compared to the same periods in 2004, primarily were due to fluctuations in net
translation gains (losses) of $0.7 million for the three-month period and ($2.2) million for the
nine-month period. In addition, net other income for the nine months ended September 30, 2004
included a gain of $6.4 million, or $0.08 per share, on a currency forward contract to
purchase pound sterling related to the acquisition of the hyperdispersants business. We secured
the forward
-38-
Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations (continued)
contract in December 2003 and completed the acquisition at the end of January 2004.
The increase in net interest expense for the nine months ended September 30, 2005 primarily was due
to the Noveon International acquisition-related financing costs. These financing costs for the
three and nine months ended September 30, 2005 were $21.0 million and $62.7 million, respectively,
compared to $21.7 million and $33.9 million for the corresponding periods in the prior year. The
2004 costs were comprised of the interest incurred on the bridge loan and assumed Noveon
International debt not repaid at the time of acquisition of $13.3 million and $19.8 million and the
amortization of bridge loan fees of $8.4 million and $11.2 million for the three and nine months
ended September 30, 2004, respectively. In addition, interest cost for the nine months ended
September 30, 2004 includes $2.9 million for the termination of an interest rate swap. We obtained
permanent transaction financing for the Noveon International acquisition in the third quarter of
2004, of which the debt component had a weighted average interest rate of 5.4% in the first nine
months of 2005.
Our effective tax rates of 32.2% and 33.6% for the three and nine months ended September 30, 2005,
respectively, compared with 38.4% and 38.2% in the same periods in 2004. The effective tax rate
for the three and nine months ended September 30, 2005 was lower than the comparable prior-year
periods mainly because of reductions in tax liabilities related to prior years.
Revenue from discontinued operations was $6.6 million and $20.3 million for the three and nine
months ended September 30, 2005, respectively, compared to $5.4 million and $11.5 million for the
corresponding periods in the prior year. Income from discontinued operations was $0.9 million and
$2.0 million for the three and nine months ended September 30, 2005, respectively, compared to $0.8
million and $0.5 million for the corresponding periods in the prior year. The three and nine
months ended September 30, 2005 included a $4.2 million pre-tax gain ($2.9 million net of tax).
Income from discontinued operations are net of tax expenses of $0.5 million and $0.7 million for
the three and nine months ended September 30, 2005, respectively, compared to tax expense of $0.1
million for the three months ended September 30, 2004 and tax credits of $0.2 million for the nine
months ended September 30, 2004.
Primarily as a result of the above factors, our basic net income per share from continuing
operations was $0.66 and $2.24 for the three and nine months ended September 30, 2005 as compared
to $0.60 and $1.41 for the comparable prior-year periods, respectively. Basic net income per share
from discontinued operations was $0.05 and $0.08 for the three and nine months ended September 30,
2005 as compared to $0.01 and $0.01 for the comparable prior-year periods, respectively. The per
share amounts from discontinued operations in 2005 consisted of $0.04 per share gain on the sale of
LPS for the three and nine months ended September 30, 2005 and $0.01 and $0.04 per share of LPS
operating income, respectively. Restructuring and impairment charges recorded in the three and
nine months ended September 30, 2005 reduced earnings by $0.07 and $0.19 per share, respectively.
Earnings in the third quarter of 2004 included a purchase adjustment associated with the increased
valuation of Noveon International-acquired inventory of $0.06 per share and a restructuring charge
for $0.13 per share and an IPR&D credit of $0.02 per share. Earnings in the first nine months of
2004 included a one-time write-off for IPR&D projects from the Noveon International acquisition of
$0.40 per share, a purchase adjustment associated with the increased valuation of Noveon
International-acquired inventory of $0.12 per share, a restructuring charge of $0.22 per share, and
a gain on a foreign currency forward contract of $0.08 per share.
SEGMENT ANALYSIS
We primarily evaluate performance and allocate resources based on segment operating income, defined
as revenues less expenses identifiable to the product lines included within each segment, as well
as projected future returns. Segment operating income will reconcile to consolidated income from
continuing operations before income taxes by deducting corporate expenses and corporate other
income (expense) that are not attributed to the operating segments, the write-off of or (credit
for) acquired IPR&D, restructuring and impairment charges and net interest expense.
-39-
Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations (continued)
The proportion of consolidated revenues and segment operating income attributed to each segment was
as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months |
|
Nine Months |
|
|
Ended September 30, |
|
Ended September 30, |
|
|
2005 |
|
2004 |
|
2005 |
|
2004 |
Revenues: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lubricant Additives |
|
|
57 |
% |
|
|
56 |
% |
|
|
56 |
% |
|
|
69 |
% |
Specialty Chemicals |
|
|
43 |
% |
|
|
44 |
% |
|
|
44 |
% |
|
|
31 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Segment
Operating Income: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lubricant Additives |
|
|
59 |
% |
|
|
69 |
% |
|
|
59 |
% |
|
|
81 |
% |
Specialty Chemicals |
|
|
41 |
% |
|
|
31 |
% |
|
|
41 |
% |
|
|
19 |
% |
The operating results by segment for the three and nine months ended September 30, 2005 and 2004
were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
|
|
|
|
|
|
|
September 30, |
|
|
|
|
|
|
|
(in millions of dollars) |
|
2005 |
|
|
2004 |
|
|
$ Change |
|
|
% Change |
Revenues: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lubricant Additives |
|
$ |
574.1 |
|
|
$ |
509.3 |
|
|
$ |
64.8 |
|
|
|
13 |
% |
Specialty Chemicals |
|
|
440.0 |
|
|
|
407.8 |
|
|
|
32.2 |
|
|
|
8 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
1,014.1 |
|
|
$ |
917.1 |
|
|
$ |
97.0 |
|
|
|
11 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended |
|
|
|
|
|
|
|
|
|
|
Excluding |
|
|
September 30, |
|
|
|
|
|
|
|
|
|
|
Acquisitions |
(in millions of dollars) |
|
2005 |
|
|
2004 |
|
|
$ Change |
|
|
% Change |
|
$ Change |
|
|
% Change |
Revenues: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lubricant Additives |
|
$ |
1,704.9 |
|
|
$ |
1,517.8 |
|
|
$ |
187.1 |
|
|
|
12 |
% |
|
$ |
187.1 |
|
|
|
12 |
% |
Specialty Chemicals |
|
|
1,333.1 |
|
|
|
693.4 |
|
|
|
639.7 |
|
|
|
92 |
% |
|
|
48.6 |
|
|
|
7 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
3,038.0 |
|
|
$ |
2,211.2 |
|
|
$ |
826.8 |
|
|
|
37 |
% |
|
$ |
235.7 |
|
|
|
11 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
-40-
Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations (continued)
The operating results by segment for the three and nine months ended September 30, 2005 and 2004
were as follows (continued from previous page):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
|
|
|
|
|
|
|
September 30, |
|
|
|
|
|
|
|
(in millions of dollars) |
|
2005 |
|
|
2004 |
|
|
$ Change |
|
|
% Change |
Gross
Profit: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lubricant Additives |
|
$ |
134.7 |
|
|
$ |
131.0 |
|
|
$ |
3.7 |
|
|
|
3 |
% |
Specialty Chemicals |
|
|
113.3 |
|
|
|
96.4 |
|
|
|
16.9 |
|
|
|
18 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
248.0 |
|
|
$ |
227.4 |
|
|
$ |
20.6 |
|
|
|
9 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended |
|
|
|
|
|
|
|
|
|
|
Excluding |
|
|
|
September 30, |
|
|
|
|
|
|
|
|
|
|
Acquisitions |
(in millions of dollars) |
|
2005 |
|
|
2004 |
|
|
$ Change |
|
|
% Change |
|
$ Change |
|
|
% Change |
Gross
Profit: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lubricant Additives |
|
$ |
416.3 |
|
|
$ |
401.5 |
|
|
$ |
14.8 |
|
|
|
4 |
% |
|
$ |
14.8 |
|
|
|
4 |
% |
Specialty Chemicals |
|
|
351.9 |
|
|
|
166.2 |
|
|
|
185.7 |
|
|
|
112 |
% |
|
|
23.3 |
|
|
|
14 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
768.2 |
|
|
$ |
567.7 |
|
|
$ |
200.5 |
|
|
|
35 |
% |
|
$ |
38.1 |
|
|
|
7 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
|
|
|
|
|
|
|
September 30, |
|
|
|
|
|
|
|
(in millions of dollars) |
|
2005 |
|
|
2004 |
|
|
$ Change |
|
|
% Change |
Segment |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating
Income: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lubricant Additives |
|
$ |
68.6 |
|
|
$ |
66.0 |
|
|
$ |
2.6 |
|
|
|
4 |
% |
Specialty Chemicals |
|
|
47.5 |
|
|
|
29.6 |
|
|
|
17.9 |
|
|
|
60 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
116.1 |
|
|
$ |
95.6 |
|
|
$ |
20.5 |
|
|
|
21 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended |
|
|
|
|
|
|
|
|
|
|
Excluding |
|
|
|
September 30, |
|
|
|
|
|
|
|
|
|
|
Acquisitions |
(in millions of dollars) |
|
2005 |
|
|
2004 |
|
|
$ Change |
|
|
% Change |
|
$ Change |
|
|
% Change |
Segment |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating
Income: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lubricant Additives |
|
$ |
220.7 |
|
|
$ |
201.6 |
|
|
$ |
19.1 |
|
|
|
9 |
% |
|
$ |
19.1 |
|
|
|
9 |
% |
Specialty Chemicals |
|
|
150.5 |
|
|
|
46.0 |
|
|
|
104.5 |
|
|
|
227 |
% |
|
|
31.5 |
|
|
|
68 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
371.2 |
|
|
$ |
247.6 |
|
|
$ |
123.6 |
|
|
|
50 |
% |
|
$ |
50.6 |
|
|
|
20 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
-41-
Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations (continued)
Lubricant Additives Segment
Revenues increased 13% and 12% for the three and nine months ended September 30, 2005,
respectively, compared to the same periods in 2004, primarily due to a 12% improvement in the
combination of price and product mix in both periods.
Shipment volume patterns vary in different geographic zones. The following table shows our
shipment volume by geographic zone for the three and nine months ended September 30, 2005.
|
|
|
|
|
|
|
|
|
|
|
3rd Quarter |
|
Year-to-Date |
|
|
2005 |
|
2005 |
|
|
Volume |
|
Volume |
North America |
|
|
37 |
% |
|
|
38 |
% |
Europe |
|
|
32 |
% |
|
|
31 |
% |
Asia-Pacific / Middle East |
|
|
25 |
% |
|
|
25 |
% |
Latin America |
|
|
6 |
% |
|
|
6 |
% |
|
|
|
|
|
Total |
|
|
100 |
% |
|
|
100 |
% |
|
|
|
|
|
The following table shows the changes in our shipment volume by geographic zone for the three and
nine months ended September 30, 2005 compared with the corresponding periods in 2004.
|
|
|
|
|
|
|
|
|
|
|
3rd Quarter |
|
Year-to-Date |
|
|
2005 vs. 2004 |
|
2005 vs. 2004 |
|
|
% Change |
|
% Change |
North America |
|
|
(4 |
%) |
|
|
(7 |
%) |
Europe |
|
|
2 |
% |
|
|
3 |
% |
Asia-Pacific / Middle East |
|
|
8 |
% |
|
|
7 |
% |
Latin America |
|
|
1 |
% |
|
|
(6 |
%) |
Total |
|
|
1 |
% |
|
|
(1 |
%) |
Although volume decreased 1% for the nine months ended September 30, 2005 compared to the same
period in 2004, this decrease included the final piece of lost business of a major international
customer in the second half of 2004 and the impact on shipment volumes of the higher concentration
associated with the new passenger car technical standard GF-4 as compared to GF-3. Excluding these
items, volume increased 4% in total and 2% in North America for the nine months ended September 30,
2005. These same factors did not significantly impact the third quarter volume comparison.
However, we estimate that Hurricane Rita negatively impacted our third quarter volumes by
approximately 1% due to delayed shipments, of which more than half were attributed to North
America. Volume for the three months ended September 30, 2005 also was negatively affected by some
customer inventory build-up in the second quarter of 2005. Higher shipment volume in Europe for
both periods primarily was due to increases in our engine additives product line due to market
share gains. The shipment volume increase in Asia-Pacific for both periods primarily was due to
market growth as well as some temporary business gains due to one of our competitors supply
difficulties. The decrease in Latin America for the nine-month period primarily was due to some
lost business within our engine additives product line and a shift in finished fluid blending
volume from Latin America to North America.
-42-
Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations (continued)
The Lubricant Additives segment has implemented a series of price increases in 2005 in response to
continued raw material cost increases as well as higher prices for natural gas and electricity used
in our plants. We implemented a price increase in April 2005 for all products sourced from North
America, Asia-Pacific and Latin America and in May 2005 for products sourced from Europe. We
implemented a second round of price increases that became effective in July 2005 for products
sourced from North America, in August 2005 for products sourced from Asia-Pacific and Latin America
and in September 2005 for shipments made to all customers in Europe and Africa. We implemented a
third round of price increases that became effective in September 2005 for products sourced from
North America and in October 2005 for products sourced from Asia-Pacific and Latin America and will
become effective in November 2005 for shipments made to all customers in Europe and Africa. In
addition, we have announced another round of price increases to become effective in November 2005
for products sourced from North America and in December 2005 for products sourced from Asia-Pacific
and Latin America. We anticipate raw material and utility costs will continue to increase in the
fourth quarter of 2005 as compared to the third quarter of 2005.
Segment gross profit includes material cost and all manufacturing expenses. Segment gross profit
increased 3% and 4% for the three and nine months ended September 30, 2005, respectively, compared
with the same periods in 2004. The increase for both periods primarily was due to the cumulative
impact of the selling price increases, partially offset by higher average raw material cost and to
a lesser extent, higher manufacturing costs as well as an increase in volume for the three-month
comparative period. Currency was a positive factor in the year-to-date comparison and a neutral
factor in the quarterly comparison. In the three and nine months ended September 30, 2005, average
material cost increased 21% and 22%, respectively, compared to the same periods in 2004. On a per
unit sold basis, manufacturing expenses remained relatively flat for the three-month comparative
periods but increased 4% for the nine months ended September 30, 2005 as compared to the prior
year. For both the three- and nine-month comparative periods, higher utilities and maintenance
costs were incurred in 2005. We incurred environmental expenses of $1.6 million and $3.4 million,
respectively, for the three and nine months ended September 30, 2004 that did not recur in 2005.
In addition, higher gross profit from our equipment company contributed 23% and 11% of the increase
in segment gross profit for the three and nine months ended September 30, 2005, respectively,
compared to the same periods in 2004.
The gross profit percentage for the segment was 23.5% and 24.4% for the three and nine months ended
September 30, 2005, respectively, compared with 25.7% and 26.5%, in the prior-year periods. The
decrease primarily was due to the time lag between the effective date of selling price increases in
the wake of raw material increases and raw material costs rising proportionally faster than selling
prices.
STAR expenses were relatively flat for the three months ended September 30, 2005 and decreased $4.3
million (2%) for the nine months ended September 30, 2005 compared to the same periods in 2004.
The decrease for the nine-month period primarily was due to lower technical expenses of $5.1
million. The decrease in technical expenses primarily was due to lower outside technical expenses.
We anticipate testing expenses will accelerate in the fourth quarter of 2005 as compared to the
first nine months of 2005.
Segment operating income increased 4% and 9% for the three and nine months ended September 30,
2005, respectively, compared with the same periods in 2004 due to the factors discussed above.
Specialty Chemicals Segment
Revenues for the Specialty Chemicals segment increased 8% for the three months ended September 30,
2005 and 92% for the nine months ended September 30, 2005 compared with the same periods in the
prior year. The increase for the three-month period was due to a 13% improvement in the
combination of price and product mix partially offset by a 5% decrease in shipment volume. The
increase for the nine-month period primarily was due to the 2004 acquisitions of Noveon
International and the hyperdispersants business. Excluding acquisitions, segment revenues
increased 7% for the nine months ended September 30, 2005 compared with the same period in the
prior year due to a 12% improvement
-43-
Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations (continued)
in the combination of price and product mix and a 1% favorable
currency impact partially offset by a 6% decrease in
shipment volume. The higher-priced product mix for both the three- and nine-month periods occurred
relatively evenly across all three of our product lines as we have implemented price increases to
offset rising raw material costs.
Shipment volume patterns vary in different geographic zones. The following table shows our
shipment volume by geographic zone for the three and nine months ended September 30, 2005.
|
|
|
|
|
|
|
|
|
|
|
3rd Quarter |
|
Year-to-Date |
|
|
2005 |
|
2005 |
|
|
Volume |
|
Volume |
North America |
|
|
71 |
% |
|
|
71 |
% |
Europe |
|
|
14 |
% |
|
|
15 |
% |
Asia-Pacific / Middle East |
|
|
11 |
% |
|
|
10 |
% |
Latin America |
|
|
4 |
% |
|
|
4 |
% |
|
|
|
|
|
Total |
|
|
100 |
% |
|
|
100 |
% |
|
|
|
|
|
The following table shows the changes in our shipment volume by geographic zone as compared with
the corresponding periods in 2004.
|
|
|
|
|
|
|
2005 vs. 2004 |
|
|
% Change |
Third Quarter: |
|
|
|
|
North America |
|
|
(5 |
%) |
Europe |
|
|
(11 |
%) |
Asia-Pacific / Middle East |
|
|
1 |
% |
Latin America |
|
|
(7 |
%) |
Total |
|
|
(5 |
%) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Excluding |
|
|
|
|
|
|
Acquisitions |
|
|
2005 vs. 2004 |
|
2005 vs. 2004 |
|
|
% Change |
|
% Change |
Year-to-Date: |
|
|
|
|
|
|
|
|
North America |
|
|
56 |
% |
|
|
(7 |
%) |
Europe |
|
|
60 |
% |
|
|
(2 |
%) |
Asia-Pacific / Middle East |
|
|
88 |
% |
|
|
|
|
Latin America |
|
|
56 |
% |
|
|
(5 |
%) |
Total |
|
|
59 |
% |
|
|
(6 |
%) |
Excluding acquisitions, the shipment volume decrease in North America for the three months ended
September 30, 2005 was due to decreases in our consumer specialties and performance coatings
product lines. The decrease for the nine months ended September 30, 2005 occurred in all product
lines. The decrease in our consumer specialties and performance coatings product lines for both
periods primarily was due to exiting certain low margin business and some
-44-
Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations (continued)
market share loss due to
competitive activity in response to our price increases. The decrease for the nine months in
specialty materials primarily was due to reduced customer buying in part because of the merger of
two large customers
and reduced business in military applications. The decrease in Europe for the three- and
nine-month periods primarily was in our consumer specialties product line because of market share
loss due to competitive activity in response to our price increases.
Segment gross profit increased $16.9 million, or 18%, for the three months ended September 30, 2005
compared with the same period in 2004 and increased $185.7 million, or 112%, (increased $23.3
million, or 14%, excluding acquisitions) for the nine months ended September 30, 2005 compared to
the same period in 2004. The increase in segment gross profit for the three-month and nine-month
(excluding acquisitions) periods primarily was due to higher revenues due to an improvement in the
combination of price and product mix partially offset by higher raw material costs and
manufacturing expenses. Material cost for the three and nine months ended September 30, 2004
includes the impact of $4.9 million and $9.8 million respectively, of inventory step-up
amortization from acquisition accounting. Excluding the impact of the step-up in 2004, average raw
material cost increased 13% for the three-month and 14% for the nine-month periods ended September
30, 2005 compared to the same periods in 2004. Manufacturing expenses increased 5% for the three
months ended September 30, 2005 and 6%, excluding acquisitions, for the nine months ended September
30, 2005, primarily due to higher spending related to utilities partially offset by a favorable
depreciation adjustment of $2.3 million in the nine months ended September 30, 2005 related to a
purchase accounting adjustment.
The gross profit percentage for this segment was 25.8% and 26.4% for the three and nine months
ended September 30, 2005, respectively, compared with 23.6% and 24.0% in the prior-year periods.
Excluding acquisitions, the gross profit percentage was 25.5% for the nine months ended September
30, 2005. Excluding the impact of the inventory step-up amortization, the gross profit percentage
for the three and nine months ended September 30, 2004 was 24.8% and 25.4%, respectively. The
increase in the gross profit percentage for the three-month and, to a
lesser extent, the nine-month
periods of 2005 compared to the same periods in 2004, excluding the impact of the inventory step-up
in 2004, primarily was due to the run-up in material costs that we began to see in the second half
of 2004 that unfavorably impacted 2004 being offset by the price increases that we began
implementing in the fourth quarter of 2004.
STAR expenses decreased $1.0 million, or 2%, for the three months ended September 30, 2005 compared
with the same period in 2004 and increased $74.7 million, or 67%, (decreased $8.2 million, or 7%,
excluding acquisitions) for the nine months ended September 30, 2005 compared with the same period
in 2004. Excluding acquisitions, the decrease in STAR expenses primarily was due to the
consolidation of some segment administrative functions into corporate functions, reduced spending
as a result of the integration of general and administrative functions and savings from a
restructuring in our Performance Coatings product line.
Segment operating income increased $17.9 million for the three months ended September 30, 2005
compared with the same period in 2004 and increased $104.5 million for the nine months ended
September 30, 2005 (increased $31.5 million excluding acquisitions), compared with the same period
in 2004. Excluding acquisitions for the nine-month period, the increase in segment operating
income for both periods primarily was due to the increase in segment gross profit and the decrease
in STAR expenses.
-45-
Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations (continued)
PRO FORMA ANALYSIS
The following table presents major components of and information derived from the pro forma
consolidated statements of income and pro forma consolidated statements of cash flows for the nine
months ended September 30, 2004. The major components of the pro forma consolidated statements of
income and pro forma consolidated statements of cash flows reflect the effect of the acquisition of
Noveon International on June 3, 2004 as if the acquisition occurred as of January 1, 2004. We
believe that this data provides the financial statement reader with information that is useful in
understanding the impact of the acquisition of Noveon International on our results of operations
and cash flows.
The components of and information derived from the pro forma consolidated statements of income and
the pro forma consolidated statements of cash flows for the nine months ended September 30, 2004
are derived from our unaudited consolidated financial statements for the nine months ended
September 30, 2004 and the unaudited consolidated financial statements of Noveon International for
the period from January 1, 2004 to the acquisition date.
Our consolidated balance sheet as of September 30, 2005 reflects the acquisition of Noveon
International under the purchase method of accounting. The allocation of the purchase price was
complete as of June 30, 2005.
The pro forma data gives effect to actual operating results of Noveon International prior to the
acquisition. Adjustments to cost of sales for the inventory step-up charge, fixed asset
depreciation, intangible asset amortization, the write-off of acquired IPR&D, interest expense and
income taxes related to the acquisition are reflected in the pro forma data. The entire inventory
step-up charge is attributable to the Specialty Chemicals segment. In addition, we assumed that
the bridge loan obtained at the time of the transaction closing was not replaced with the permanent
long-term financing of both debt and equity until the end of April, the fourth month in the period
presented. These pro forma amounts do not purport to be indicative of the results that actually
would have been obtained if the acquisition had occurred as of the beginning of the period
presented or that may be obtained in the future.
-46-
Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations (continued)
The following table summarizes the pro forma data for 2004 compared to actual data for 2005:
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended |
|
|
|
September 30, |
|
|
|
|
|
|
|
Pro Forma |
|
(in millions of dollars) |
|
Actual 2005 |
|
|
2004 |
|
Consolidated Data |
|
|
|
|
|
|
|
|
Total revenues |
|
$ |
3,038.0 |
|
|
$ |
2,748.8 |
|
|
|
|
|
|
|
|
Gross profit |
|
$ |
768.2 |
|
|
$ |
729.1 |
|
|
|
|
|
|
|
|
Income before income taxes |
|
$ |
229.4 |
|
|
$ |
150.3 |
|
|
|
|
|
|
|
|
Income from continuing operations |
|
$ |
152.3 |
|
|
$ |
96.2 |
|
|
|
|
|
|
|
|
Net income |
|
$ |
157.2 |
|
|
$ |
96.6 |
|
|
|
|
|
|
|
|
Depreciation expense |
|
$ |
116.7 |
|
|
$ |
122.0 |
|
|
|
|
|
|
|
|
Amortization of intangible assets |
|
$ |
18.9 |
|
|
$ |
18.7 |
|
|
|
|
|
|
|
|
Capital expenditures |
|
$ |
91.5 |
|
|
$ |
105.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Segment Data |
|
|
|
|
|
|
|
|
Lubricant Additives Segment |
|
|
|
|
|
|
|
|
Total revenues |
|
$ |
1,704.9 |
|
|
$ |
1,517.8 |
|
|
|
|
|
|
|
|
Gross profit |
|
$ |
416.3 |
|
|
$ |
401.5 |
|
|
|
|
|
|
|
|
Segment operating income |
|
$ |
220.7 |
|
|
$ |
201.6 |
|
|
|
|
|
|
|
|
Depreciation expense |
|
$ |
60.0 |
|
|
$ |
64.2 |
|
|
|
|
|
|
|
|
Amortization of intangible assets |
|
$ |
2.3 |
|
|
$ |
2.3 |
|
|
|
|
|
|
|
|
Capital expenditures |
|
$ |
50.1 |
|
|
$ |
58.4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Specialty Chemicals Segment |
|
|
|
|
|
|
|
|
Total revenues |
|
$ |
1,333.1 |
|
|
$ |
1,231.0 |
|
|
|
|
|
|
|
|
Gross profit |
|
$ |
351.9 |
|
|
$ |
327.6 |
|
|
|
|
|
|
|
|
Segment operating income |
|
$ |
150.5 |
|
|
$ |
117.7 |
|
|
|
|
|
|
|
|
Depreciation expense |
|
$ |
56.1 |
|
|
$ |
56.9 |
|
|
|
|
|
|
|
|
Amortization of intangible assets |
|
$ |
16.6 |
|
|
$ |
16.4 |
|
|
|
|
|
|
|
|
Capital expenditures |
|
$ |
41.1 |
|
|
$ |
46.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unallocated corporate depreciation
expense |
|
$ |
0.6 |
|
|
$ |
0.9 |
|
|
|
|
|
|
|
|
Unallocated corporate capital
expenditures |
|
$ |
0.3 |
|
|
$ |
0.6 |
|
|
|
|
|
|
|
|
-47-
Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations (continued)
Comparative pro forma data (continued):
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended |
|
|
|
September 30, |
|
(in millions of dollars) |
|
Actual 2005 |
|
|
Pro Forma 2004 |
|
Reconciliation of Segment Operating
Income to Income from Continuing
Operations before Income Taxes |
|
|
|
|
|
|
|
|
|
Segment operating income: |
|
|
|
|
|
|
|
|
Lubricant Additives Segment |
|
$ |
220.7 |
|
|
$ |
201.6 |
|
Specialty Chemicals Segment |
|
|
150.5 |
|
|
|
117.7 |
|
|
|
|
|
|
|
|
Total segment operating income |
|
|
371.2 |
|
|
|
319.3 |
|
|
|
|
|
|
|
|
|
|
Corporate expenses |
|
|
(47.4 |
) |
|
|
(32.3 |
) |
Corporate other income (expenses) |
|
|
(1.1 |
) |
|
|
2.8 |
|
Write-off of acquired IPR&D |
|
|
|
|
|
|
(34.0 |
) |
Restructuring and impairment charges |
|
|
(18.9 |
) |
|
|
(21.2 |
) |
Interest
expense net |
|
|
(74.4 |
) |
|
|
(84.3 |
) |
|
|
|
|
|
|
|
Income from
continuing operations before income taxes
|
|
$ |
229.4 |
|
|
$ |
150.3 |
|
|
|
|
|
|
|
|
WORKING CAPITAL, LIQUIDITY AND CAPITAL RESOURCES
The following table summarizes the major components of cash flow:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended |
|
|
|
|
|
|
September 30, |
|
|
|
|
(in millions of dollars) |
|
2005 |
|
|
2004 |
|
|
$ Change |
|
Cash provided by (used for): |
|
|
|
|
|
|
|
|
|
|
|
|
Operating activities |
|
$ |
283.8 |
|
|
$ |
192.6 |
|
|
$ |
91.2 |
|
Investing activities |
|
|
(74.5 |
) |
|
|
(1,039.1 |
) |
|
|
964.6 |
|
Financing activities |
|
|
(281.6 |
) |
|
|
864.5 |
|
|
|
(1,146.1 |
) |
Effect of exchange rate changes on cash |
|
|
(10.7 |
) |
|
|
7.4 |
|
|
|
(18.1 |
) |
|
|
|
|
|
|
|
|
|
|
|
Net increase (decrease) in cash and
short-term investments |
|
$ |
(83.0 |
) |
|
$ |
25.4 |
|
|
$ |
(108.4 |
) |
|
|
|
|
|
|
|
|
|
|
-48-
Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations (continued)
Operating Activities
The increase in cash provided by operating activities in the nine months ended September 30, 2005
compared with the prior year primarily was due to an increase in earnings after adjusting for
non-cash items. The increase in earnings partially was offset by a $73.3 million increase in
receivables since December 31, 2004. This compares to a $79.5 million increase in receivables in
the prior-year comparable period. The year-end seasonality in sales and collections for the
holidays is a significant contributing factor related to the change in the receivables balance
since December 31, 2004.
We manage our levels of inventories and accounts receivable on the basis of average days sales in
inventory and average days sales in receivables. Our target for accounts receivable is established
taking into consideration the weighted average of our various terms of trade for each segment. Our
target for days sales in inventory for each segment is established with the goal of minimizing our
investment in inventories while at the same time ensuring adequate supply for our customers.
Improvement in both the timing of cash collections and inventory turns helped mitigate the increase
in working capital due to higher average selling price and higher inventory costs. We continue to
expect incremental improvement in the days sales metrics as compared to 2004 by the end of the
year.
Investing Activities
Our capital expenditures for the nine months ended September 30, 2005 were $91.5 million, as
compared with $82.4 million for the same period in 2004. In 2005, we estimate annual capital
expenditures will be approximately $140.0 to $145.0 million, including $6.0 million of capital
expenditures related to the transfer of production from the three manufacturing facilities
scheduled for closure to other facilities.
The net decrease in cash used to fund acquisitions in the first nine months of 2005 as compared to
the prior year relates to the acquisitions of the hyperdispersants business of Avecia in January
2004 and Noveon International in June 2004. The increase in net proceeds from divestitures and
sale of property relates primarily to net cash received from the sale of the LPS business of $13.5
million in September 2005.
Financing Activities
The decrease in cash provided by financing activities of $281.6 million in the nine months ended
September 30, 2005 primarily was due to the $475.0 million
in term-loan principal payments made during 2005,
offset by borrowings of 175.0 million against the euro revolving credit agreement in September
2005 as compared to an increase in borrowings of $1,797.0 million under our then $2,450.0 million
364-day bridge facility in June 2004, the proceeds of which were used to fund the Noveon
International acquisition and repay related assumed debt of $1,103.1 million.
Capitalization, Liquidity and Credit Facilities
On September 14, 2005, three of our wholly owned foreign subsidiaries entered into a new five-year
unsecured 250.0 million revolving credit agreement. This credit agreement permits these
foreign subsidiaries to borrow at variable rates based on EURIBOR plus a specified credit
spread. We have guaranteed all obligations of the borrowers under the credit agreement. On
September 20, 2005, Europe Chemical Holdings C.V. borrowed 175.0 million under this agreement.
In the three and nine months ended September 30, 2005, we repaid $350.0 million and $475.0 million,
respectively, against the bank term loan. The balance outstanding at September 30, 2005 under the
term loan was $25.0 million.
At September 30, 2005, our total debt outstanding of $1,692.6 million consisted of 62% fixed-rate
debt and 38% variable-rate debt, including $400.0 million of fixed-rate debt that effectively has
been swapped to variable-rate debt. Our weighted-average borrowing rate as of September 30, 2005
was approximately 5.4%.
-49-
Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations (continued)
A major
activity this year has been to repatriate overseas cash. By the end
of the third quarter, we had repatriated $233.6 million of foreign
subsidiary cash towards our current year goal of $250.0 million. We
expect to bring back the remainder in the fourth quarter. In
addition, we have repatriated another $213.8 million
through the euro bank facility entered into in September 2005.
Our net debt to capitalization ratio at
September 30, 2005 was 48%. Net debt is the total of
short-term and long-term debt, reduced by cash and short-term investments excluding original issue
discounts and unrealized gains and losses on derivative instruments designated as fair-value hedges
of fixed-rate debt. Capitalization is shareholders equity plus net debt. Total debt as a percent
of capitalization was 52% at September 30, 2005.
Our ratio of current assets to current liabilities decreased from 2.4 at December 31, 2004 to 2.3
at September 30, 2005, primarily due to decreases in cash and short term investments due to the
repayment of $350.0 million against the bank term loan in the quarter, offset by borrowings of
175.0 million from the euro revolving credit facility, working capital increases associated
with higher sales and the timing of collections and disbursements. The increase in accounts
receivable of $37.5 million since December 31, 2004 primarily was driven by higher sales in the
third quarter of 2005 as compared to the fourth quarter of 2004 as well as seasonality.
At September 30, 2005, we had a $500.0 million revolving credit facility that matures in August
2009, which allows us to borrow at variable rates based upon the U.S. prime rate or LIBOR plus a
specified credit spread. As of September 30, 2005, we had no outstanding borrowings under this
agreement.
On March 29, 2005, we amended and restated our five-year unsecured bank credit agreement to reduce
the credit spread paid on the outstanding $500.0 million term loan. Based on our current unsecured
senior debt ratings from Standard and Poors and Moodys Investors Services, the credit spread on
the term loan was reduced by 50 basis points. No other terms or conditions of the agreement were
modified.
Contractual Cash Obligations
Our contractual cash obligations as of December 31, 2004 are contained on page 21 of our 2004
Annual Report to shareholders. During the first nine months of 2005, we made $475.0 million in
term-loan payments and borrowed 175.0 million against the euro revolving credit agreement.
Other than this net decrease in total debt of over $250.0 million, we do not believe there have
been any other significant changes since December 31, 2004 in that information.
Our debt level will require us to dedicate a significant portion of our cash flow to make interest
and principal payments, thereby reducing the availability of our cash flow for acquisitions or
other purposes. Nevertheless, we believe our future operating cash flows will be sufficient to
cover our debt repayments, capital expenditures, dividends and other obligations and that we have
untapped borrowing capacity that can provide us with additional financial resources. We currently
have a shelf registration statement filed with the Securities and Exchange Commission (SEC) under
which $359.8 million of debt securities, preferred shares or common shares may be issued. In
addition, as of September 30, 2005, we maintained cash and short-term investment balances of $252.9
million and had $500.0 million available under our revolving U.S. credit facility and another
75.0 million available under our revolving European facility.
NEW ACCOUNTING STANDARDS
In May 2005, the Financial Accounting Standards Board (FASB) issued SFAS No. 154, Accounting
Changes and Error Corrections. This standard establishes new standards on accounting for changes
in accounting principles. Pursuant to the new rules, all such changes must be accounted for by
retrospective application to the financial
-50-
Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations (continued)
statements of prior periods unless it is impracticable
to do so. SFAS No. 154 completely replaces Accounting Principles Board
(APB) Opinion No. 20 and SFAS No. 3, though it carries forward the guidance in those pronouncements
with respect to accounting for changes in estimates, changes in the reporting entity, and the
correction of errors. This statement is effective for accounting changes and corrections of errors
completed by the company starting January 1, 2006. We do not believe the adoption of this standard
will have a material impact on our financial position, results of operations or cash flows.
In March 2005, the FASB issued Interpretation (FIN) No. 47, Accounting for Conditional
Asset-Retirement Obligations. This standard codifies SFAS No. 143, Asset-Retirement
Obligations, and states that companies must recognize a liability for the fair value of a legal
obligation to perform asset-retirement obligations that are conditional on a future event if the
amount can be reasonably estimated. Specifically, FIN No. 47 provides additional guidance on
whether the fair value is reasonably estimable. FIN No. 47 is effective for the company starting
December 31, 2005. We do not believe the adoption of this standard will have a material impact on
our financial position, results of operations or cash flows.
In December 2004, the FASB issued SFAS No. 123(R), Share-Based Payment. This standard will
require compensation costs related to share-based payment transactions to be recognized in the
financial statements. With limited exceptions, the amount of compensation cost will be measured
based on the grant-date fair value of the equity or liability instruments issued. In addition,
liability awards will be remeasured each reporting period. Compensation cost will be recognized
over the period that an employee provides service in exchange for the award. This standard
replaces SFAS No. 123 and supersedes APB Opinion No. 25, Accounting for Stock Issued to
Employees, and applies to all awards granted, modified, repurchased or cancelled after July 1,
2005. In April 2005, the SEC amended the compliance date of SFAS No. 123(R) through an amendment
of Regulation S-X. The new effective date for us is January 1, 2006. We are currently evaluating
the provisions of this standard to determine the impact on our consolidated financial statements.
It is, however, expected to reduce consolidated net income.
In December 2004, the FASB issued SFAS No. 153, Exchanges of Nonmonetary Assets. This standard
amended APB Opinion No. 29, Accounting for Nonmonetary Transactions, to eliminate the exception
from fair value measurement for nonmonetary exchanges of similar productive assets. This standard
replaces this exception with a general exception from fair value measurement for exchanges of
nonmonetary assets that do not have commercial substance. A nonmonetary exchange has commercial
substance if the future cash flows of the entity are expected to change significantly as a result
of the exchange. The provisions of SFAS No. 153 are
effective for nonmonetary asset exchanges occurring in fiscal periods
beginning after June 15, 2005. Our adoption of this
standard did not have a material impact on the financial statements.
In November 2004, the FASB issued SFAS No. 151, Inventory Costs, to clarify the accounting for
abnormal amounts of idle facility expense, freight, handling costs and wasted material. This
standard requires that such items be recognized as current-period charges. The standard also
establishes the concept of normal capacity and requires the allocation of fixed production
overhead to inventory based on the normal capacity of the production facilities. Any unallocated
overhead must be recognized as an expense in the period incurred. This standard is effective for
inventory costs incurred starting January 1, 2006. We do not believe the adoption of this standard
will have a material impact on our financial position, results of operations or cash flows.
-51-
Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations (continued)
CAUTIONARY STATEMENTS FOR SAFE HARBOR PURPOSES
This Managements Discussion and Analysis of Financial Condition and Results of Operations contains
forward-looking statements within the meaning of the federal securities laws. As a general matter,
forward-looking statements are those focused upon future plans, objectives or performance as
opposed to historical items and include statements of anticipated events or trends and expectations
and beliefs relating to matters not historical in nature. Forward-looking statements are subject
to uncertainties and factors relating to our operations and business environment, all of which are
difficult to predict and many of which are beyond our control. These uncertainties and factors
could cause our actual results to differ materially from those matters expressed in or implied by
any forward-looking statements, although we believe our expectations reflected in those
forward-looking statements are based upon reasonable assumptions. For this purpose, any statements
contained herein that are not statements of historical fact should be deemed to be forward-looking
statements.
We believe that the following factors, among others, could affect our future performance and cause
our actual results to differ materially from those expressed or implied by forward-looking
statements made in this quarterly report:
|
|
the cost, availability and quality of raw materials, including petroleum-based products; |
|
|
|
our ability to increase the prices of our products in a competitive environment; |
|
|
|
the effect of required principal and interest payments on our ability to fund capital expenditures and acquisitions and
to meet operating needs; |
|
|
|
the overall global economic environment and the overall demand for our products on a worldwide basis; |
|
|
|
technology developments that affect longer-term trends for our products; |
|
|
|
the extent to which we are successful in expanding our business in new and existing markets; |
|
|
|
our ability to identify, complete and integrate acquisitions for profitable growth and operating efficiencies,
especially our ability to integrate the acquisition of Noveon International; |
|
|
|
our success at continuing to develop proprietary technology to meet or exceed new industry performance standards and
individual customer expectations; |
|
|
|
our ability to continue to reduce complexities and conversion costs and modify our cost structure to maintain and
enhance our competitiveness; |
|
|
|
our success in retaining and growing the business that we have with our largest customers; |
|
|
|
the cost and availability of energy, including natural gas and electricity; |
|
|
|
the effect of interest rate fluctuations on our interest expense; |
|
|
|
the effects of fluctuations in currency exchange rates upon our reported results from international operations,
together with non-currency risks of investing in and conducting significant operations in foreign countries, including
those relating to political, social, economic and regulatory factors; |
|
|
|
the extent to which we achieve market acceptance of our commercial development programs; |
|
|
|
significant changes in government regulations affecting environmental compliance; |
|
|
|
the ability to identify, understand and manage risks inherent in new markets in which we choose to expand; and |
|
|
|
our ability to maintain operating continuity for those businesses identified as divestiture candidates. |
-52-
Item 3. Quantitative and Qualitative Disclosures About Market Risk
We operate manufacturing and blending facilities, laboratories and offices around the world and
utilize fixed and variable rate debt to finance our global operations. As a result, we are subject
to business risks inherent in non-U.S. activities, including political and economic uncertainties,
import and export limitations, and market risks related to changes in interest rates and foreign
currency exchange rates. We believe the political and economic risks related to our foreign
operations are mitigated due to the stability of the countries in which our largest foreign
operations are located.
In the normal course of business, we use derivative financial instruments including interest rate
and commodity hedges and forward foreign currency exchange contracts to manage our market risks.
Our objective in managing our exposure to changes in interest rates is to limit the impact of such
changes on our earnings and cash flow. Our objective in managing the exposure to changes in
foreign currency exchange rates is to reduce volatility on our earnings and cash flow associated
with such changes. Our principal currency exposures are the euro, the pound sterling, the Japanese
yen and certain Latin American currencies. Our objective in managing our exposure to changes in
commodity prices is to reduce the volatility on earnings of utility expense. We do not hold
derivatives for trading purposes.
We measure our market risk related to our holdings of financial instruments based on changes in
interest rates, foreign currency rates and commodity prices utilizing a sensitivity analysis. The
sensitivity analysis measures the potential loss in fair value, cash flow and earnings based on a
hypothetical 10% change (increase and decrease) in interest, currency exchange rates and commodity
prices. We use current market rates on our debt and derivative portfolios to perform the
sensitivity analysis. Certain items such as lease contracts, insurance contracts and obligations
for pension and other postretirement benefits are not included in the analysis.
Our primary interest rate exposures relate to our cash and short-term investments, fixed and
variable rate debt and interest rate swaps. The calculation of potential loss in fair value is
based on an immediate change in the net present values of our interest rate-sensitive exposures
resulting from a 10% change in interest rates. The potential loss in cash flow and income before
tax is based on the change in the net interest income/expense over a one-year period due to an
immediate 10% change in rates. A hypothetical 10% increase in interest rates would have had a
favorable impact and a hypothetical 10% decrease in interest rates would have had an unfavorable
impact on fair values of $43.7 million in 2005. In addition, a hypothetical 10% increase in
interest rates would have had an unfavorable impact and a hypothetical 10% decrease in interest
rates would have had a favorable impact on cash flows and income before tax of $2.1 million in 2005
on an annualized basis.
Our primary currency rate exposures are to foreign-denominated debt, intercompany loans, cash and
short-term investments and forward foreign currency exchange contracts. The calculation of
potential loss in fair value is based on an immediate change in the U.S. dollar equivalent balances
of our foreign currency exposures due to a 10% shift in exchange rates. The potential loss in cash
flow and income before tax is based on the change in cash flow and income before tax over a
one-year period resulting from an immediate 10% change in foreign currency exchange rates. A
hypothetical 10% increase in foreign currency exchange rates would have had a favorable impact and
a hypothetical 10% decrease in foreign currency exchange rates would have had an unfavorable impact
on fair values of $9.1 million, on annualized cash flows of $22.9 million and on annualized income
before tax of $8.5 million in 2005.
Our primary commodity hedge exposures relate to natural gas and electric utility expenses. The
calculation of potential loss in fair value is based on an immediate change in the U.S. dollar
equivalent balances of our commodity exposures due to a 10% shift in the underlying commodity
prices. The potential loss in cash flow and income before tax is based on the change in cash flow
and income before tax over a one-year period resulting from an immediate 10% change in commodity
prices. A hypothetical 10% increase in commodity prices would have had a favorable impact and a
hypothetical 10% decrease in commodity prices would have had an unfavorable impact on fair values
of $0.9 million and on annualized cash flows and income before tax of $0.9 million.
-53-
Item 4. Controls and Procedures
We evaluated, under the supervision and with the participation of our chief executive officer and
chief financial officer, the effectiveness of our disclosure controls and procedures (as defined in
Exchange Act Rule 13a-15(e)) as of September 30, 2005. Based on that evaluation, our chief
executive officer and chief financial officer concluded that, as of September 30, 2005, our
disclosure controls and procedures were effective in timely alerting them to material information
relating to Lubrizol and our consolidated subsidiaries required to be included in our periodic SEC
filings. There were no significant changes in our internal control over financial reporting that
occurred during the third quarter of 2005 that have materially affected, or are reasonably likely
to materially affect, our internal control over financial reporting.
PART II. OTHER INFORMATION
Item 1. Legal Proceedings
In the third quarter of 2005, we were notified by the Seattle office of the U.S. Environmental
Protection Agency (EPA) that it is proposing a penalty against the company in connection with a
small release of ammonia that occurred at our Specialty Chemicals Kalama, Washington plant in May
2005. The EPAs Seattle office has proposed a penalty of approximately $0.7 million, which we
believe is excessive under the circumstances. We currently are discussing those circumstances with
the regulators. No enforcement proceeding has been commenced at this time.
The patent infringement suit filed against the company by Afton Chemical Company in federal court
in Virginia in the second quarter of 2005 was dismissed with finality on October 27, 2005. We
incurred no liability.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
|
(a) |
|
On July 18, 2005, we issued 62 common shares in transactions exempt from
registration under the Securities Act of 1939 pursuant to Regulation S. We issued the
common shares under an employee benefit plan to two employees of a wholly owned Canadian
subsidiary of the company. |
|
|
|
|
On August 1, 2005, we issued 5,120 common shares in private placement transactions
exempt from registration under the Securities Act of 1933 pursuant to Section 4(2) of
that Act. We issued the common shares to two former officers under deferred
compensation plans for officers. |
|
|
|
|
On September 1, 2005, we issued 282 common shares in private placement transactions
exempt from registration under the Securities Act of 1933 pursuant to Section 4(2) of
that Act. We issued the common shares to two former officers under a deferred
compensation plan for officers. |
|
|
(c) |
|
The following table provides information regarding the companys purchases of
its common shares during the third quarter. |
-54-
Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds (continued)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(d) Maximum Number |
|
|
|
|
|
|
|
|
|
|
(c) Total Number |
|
(or Approximate Dollar |
|
|
|
|
|
|
|
|
|
|
of Shares (or Units) |
|
Value) of Shares (or |
|
|
(a) Total Number of |
|
(b) Average Price |
|
Purchased as Part of |
|
Units) that May Yet |
|
|
Shares (or Units) |
|
Paid per Share |
|
Publicly Announced |
|
be Purchased Under the |
Period |
|
Purchased1 |
|
(or Unit) |
|
Plans or Programs |
|
Plans or Programs |
Month #1 |
|
|
|
|
|
|
|
|
|
|
|
|
(July 1, 2005 through
July 31, 2005) |
|
17,941 Shares |
|
$ |
43.93 |
|
|
N/A |
|
N/A |
Month #2 |
|
|
|
|
|
|
|
|
|
|
|
|
(August 1, 2005 through
August 31, 2005) |
|
8,002 Shares |
|
$ |
42.54 |
|
|
N/A |
|
N/A |
Month #3 |
|
|
|
|
|
|
|
|
|
|
|
|
(September 1, 2005
through
September 30, 2005) |
|
10,942 Shares |
|
$ |
41.29 |
|
|
N/A |
|
N/A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
36,885 Shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
This column represents common shares that were purchased by the company pursuant to: |
|
|
|
|
|
(a) |
|
our option plan, whereby participants exchange already
owned shares to us to pay for the exercise price of an option or whereby we
withhold shares upon the exercise of an option to pay the withholding taxes
on behalf of the employee. |
|
|
(b) |
|
our deferred compensation plans, whereby we withhold
shares upon a distribution to pay the withholding taxes on behalf of the
employee. |
Item 6. Exhibits
|
31.1 |
|
Rule 13a-14(a) Certification of the Chief Executive
Officer, as created by
Section 302 of the Sarbanes-Oxley Act of 2002. |
|
|
31.2 |
|
Rule 13a-14(a) Certification of the Chief Financial Officer, as created by
Section 302 of the Sarbanes-Oxley Act of 2002. |
|
|
32.1 |
|
Certification of the Chief Executive Officer and Chief Financial Officer of The
Lubrizol Corporation pursuant to 18 U.S.C. Section 1350, as created by Section 906 of
the Sarbanes-Oxley Act. |
Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused
this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
|
|
|
|
|
THE LUBRIZOL CORPORATION
|
|
|
/s/ W. Scott Emerick
|
|
|
W. Scott Emerick |
|
|
Chief Accounting Officer and Duly Authorized
Signatory of The Lubrizol Corporation |
|
|
Date: November 3, 2005
-55-